Document:

exv4w8

Exhibit 4.8

RXI PHARMACEUTICALS CORPORATION

and

                                        , as Trustee

INDENTURE

Dated as of           ,           

 

 

TABLE OF CONTENTS

	 	 	 	 	 
	 	 	PAGE	 
	ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE
	 	 	1	 
	 
	 	 	 	 
	1.1. DEFINITIONS
	 	 	1	 
	 
	 	 	 	 
	1.2. OTHER DEFINITIONS 
	 	 	5	 
	 
	 	 	 	 
	1.3. INCORPORATION BY REFERENCE OF TRUST INDENTURE ACT 
	 	 	6	 
	 
	 	 	 	 
	1.4. RULES OF CONSTRUCTION 
	 	 	6	 
	 
	 	 	 	 
	ARTICLE 2 THE SECURITIES
	 	 	7	 
	 
	 	 	 	 
	2.1. ISSUABLE IN SERIES 
	 	 	7	 
	 
	 	 	 	 
	2.2. ESTABLISHMENT OF TERMS OF SERIES OF SECURITIES 
	 	 	7	 
	 
	 	 	 	 
	2.3. EXECUTION AND AUTHENTICATION 
	 	 	9	 
	 
	 	 	 	 
	2.4. REGISTRAR AND PAYING AGENT 
	 	 	10	 
	 
	 	 	 	 
	2.5. PAYING AGENT TO HOLD ASSETS IN TRUST 
	 	 	11	 
	 
	 	 	 	 
	2.6. SECURITYHOLDER LISTS 
	 	 	12	 
	 
	 	 	 	 
	2.7. TRANSFER AND EXCHANGE 
	 	 	12	 
	 
	 	 	 	 
	2.8. REPLACEMENT SECURITIES 
	 	 	12	 
	 
	 	 	 	 
	2.9. OUTSTANDING SECURITIES 
	 	 	13	 
	 
	 	 	 	 
	2.10. WHEN TREASURY SECURITIES DISREGARDED; DETERMINATION OF HOLDERS’ ACTION 
	 	 	13	 
	 
	 	 	 	 
	2.11. TEMPORARY SECURITIES 
	 	 	14	 
	 
	 	 	 	 
	2.12. CANCELLATION 
	 	 	14	 
	 
	 	 	 	 
	2.13. PAYMENT OF INTEREST; DEFAULTED INTEREST; COMPUTATION OF INTEREST 
	 	 	14	 
	 
	 	 	 	 
	2.14. CUSIP NUMBER 
	 	 	15	 
	 
	 	 	 	 
	2.15. PROVISIONS FOR GLOBAL SECURITIES 
	 	 	15	 
	 
	 	 	 	 
	2.16. PERSONS DEEMED OWNERS 
	 	 	16	 
	 
	 	 	 	 
	ARTICLE 3 REDEMPTION
	 	 	16	 
	 
	 	 	 	 
	3.1. NOTICES TO TRUSTEE 
	 	 	16	 
	 
	 	 	 	 
	3.2. SELECTION BY TRUSTEE OF SECURITIES TO BE REDEEMED 
	 	 	17	 
	 
	 	 	 	 
	3.3. NOTICE OF REDEMPTION 
	 	 	17	 
	 
	 	 	 	 
	3.4. EFFECT OF NOTICE OF REDEMPTION 
	 	 	18	 
	 
	 	 	 	 
	3.5. DEPOSIT OF REDEMPTION PRICE 
	 	 	18	 
	 
	 	 	 	 
	3.6. SECURITIES REDEEMED IN PART 
	 	 	19	 

-i-

 

TABLE OF CONTENTS
(continued)

	 	 	 	 	 
	 	 	PAGE	 
	ARTICLE 4 COVENANTS
	 	 	19	 
	 
	 	 	 	 
	4.1. PAYMENT OF SECURITIES 
	 	 	19	 
	 
	 	 	 	 
	4.2. SEC REPORTS 
	 	 	19	 
	 
	 	 	 	 
	4.3. WAIVER OF STAY, EXTENSION OR USURY LAWS 
	 	 	20	 
	 
	 	 	 	 
	4.4. COMPLIANCE CERTIFICATE 
	 	 	20	 
	 
	 	 	 	 
	4.5. CORPORATE EXISTENCE 
	 	 	20	 
	 
	 	 	 	 
	ARTICLE 5 SUCCESSOR CORPORATION
	 	 	21	 
	 
	 	 	 	 
	5.1. LIMITATION ON CONSOLIDATION, MERGER AND SALE OF ASSETS 
	 	 	21	 
	 
	 	 	 	 
	5.2. SUCCESSOR PERSON SUBSTITUTED 
	 	 	21	 
	 
	 	 	 	 
	ARTICLE 6 DEFAULTS AND REMEDIES
	 	 	22	 
	 
	 	 	 	 
	6.1. EVENTS OF DEFAULT 
	 	 	22	 
	 
	 	 	 	 
	6.2. ACCELERATION 
	 	 	23	 
	 
	 	 	 	 
	6.3. REMEDIES 
	 	 	23	 
	 
	 	 	 	 
	6.4. WAIVER OF PAST DEFAULTS AND EVENTS OF DEFAULT 
	 	 	24	 
	 
	 	 	 	 
	6.5. CONTROL BY MAJORITY 
	 	 	24	 
	 
	 	 	 	 
	6.6. LIMITATION ON SUITS 
	 	 	24	 
	 
	 	 	 	 
	6.7. RIGHTS OF HOLDERS TO RECEIVE PAYMENT 
	 	 	25	 
	 
	 	 	 	 
	6.8. COLLECTION SUIT BY TRUSTEE 
	 	 	25	 
	 
	 	 	 	 
	6.9. TRUSTEE MAY FILE PROOFS OF CLAIM 
	 	 	25	 
	 
	 	 	 	 
	6.10. PRIORITIES 
	 	 	26	 
	 
	 	 	 	 
	6.11. UNDERTAKING FOR COSTS 
	 	 	26	 
	 
	 	 	 	 
	ARTICLE 7 TRUSTEE
	 	 	27	 
	 
	 	 	 	 
	7.1. DUTIES OF TRUSTEE 
	 	 	27	 
	 
	 	 	 	 
	7.2. RIGHTS OF TRUSTEE 
	 	 	28	 
	 
	 	 	 	 
	7.3. INDIVIDUAL RIGHTS OF TRUSTEE 
	 	 	29	 
	 
	 	 	 	 
	7.4. TRUSTEE’S DISCLAIMER 
	 	 	29	 
	 
	 	 	 	 
	7.5. NOTICE OF DEFAULT 
	 	 	29	 
	 
	 	 	 	 
	7.6. REPORTS BY TRUSTEE TO HOLDERS 
	 	 	29	 
	 
	 	 	 	 
	7.7. COMPENSATION AND INDEMNITY 
	 	 	30	 
	 
	 	 	 	 
	7.8. REPLACEMENT OF TRUSTEE 
	 	 	30	 

-ii-

 

TABLE OF CONTENTS
(continued)

	 	 	 	 	 
	 	 	PAGE	 
	7.9. SUCCESSOR TRUSTEE BY CONSOLIDATION, MERGER OR CONVERSION 
	 	 	31	 
	 
	 	 	 	 
	7.10. ELIGIBILITY; DISQUALIFICATION 
	 	 	31	 
	 
	 	 	 	 
	7.11. PREFERENTIAL COLLECTION OF CLAIMS AGAINST COMPANY 
	 	 	32	 
	 
	 	 	 	 
	7.12. PAYING AGENTS 
	 	 	32	 
	 
	 	 	 	 
	ARTICLE 8 AMENDMENTS, SUPPLEMENTS AND WAIVERS
	 	 	32	 
	 
	 	 	 	 
	8.1. WITHOUT CONSENT OF HOLDERS 
	 	 	32	 
	 
	 	 	 	 
	8.2. WITH CONSENT OF HOLDERS 
	 	 	33	 
	 
	 	 	 	 
	8.3. COMPLIANCE WITH TRUST INDENTURE ACT 
	 	 	34	 
	 
	 	 	 	 
	8.4. REVOCATION AND EFFECT OF CONSENTS 
	 	 	34	 
	 
	 	 	 	 
	8.5. NOTATION ON OR EXCHANGE OF SECURITIES 
	 	 	35	 
	 
	 	 	 	 
	8.6. TRUSTEE TO SIGN AMENDMENTS, ETC.
	 	 	35	 
	 
	 	 	 	 
	ARTICLE 9 DISCHARGE OF INDENTURE; DEFEASANCE
	 	 	35	 
	 
	 	 	 	 
	9.1. DISCHARGE OF INDENTURE 
	 	 	35	 
	 
	 	 	 	 
	9.2. LEGAL DEFEASANCE 
	 	 	36	 
	 
	 	 	 	 
	9.3. COVENANT DEFEASANCE 
	 	 	36	 
	 
	 	 	 	 
	9.4. CONDITIONS TO LEGAL DEFEASANCE OR COVENANT DEFEASANCE 
	 	 	37	 
	 
	 	 	 	 
	9.5. DEPOSITED MONEY AND U.S. AND FOREIGN GOVERNMENT OBLIGATIONS TO BE HELD
IN TRUST; OTHER MISCELLANEOUS PROVISIONS 
	 	 	38	 
	 
	 	 	 	 
	9.6. REINSTATEMENT 
	 	 	39	 
	 
	 	 	 	 
	9.7. MONEYS HELD BY PAYING AGENT 
	 	 	39	 
	 
	 	 	 	 
	9.8. MONEYS HELD BY TRUSTEE 
	 	 	39	 
	 
	 	 	 	 
	ARTICLE 10 MISCELLANEOUS
	 	 	40	 
	 
	 	 	 	 
	10.1. TRUST INDENTURE ACT CONTROLS 
	 	 	40	 
	 
	 	 	 	 
	10.2. NOTICES 
	 	 	40	 
	 
	 	 	 	 
	10.3. COMMUNICATIONS BY HOLDERS WITH OTHER HOLDERS 
	 	 	41	 
	 
	 	 	 	 
	10.4. CERTIFICATE AND OPINION AS TO CONDITIONS PRECEDENT 
	 	 	41	 
	 
	 	 	 	 
	10.5. STATEMENT REQUIRED IN CERTIFICATE AND OPINION 
	 	 	42	 
	 
	 	 	 	 
	10.6. RULES BY TRUSTEE AND AGENTS 
	 	 	42	 
	 
	 	 	 	 
	10.7. BUSINESS DAYS; LEGAL HOLIDAYS; PLACE OF PAYMENT 
	 	 	42	 
	 
	 	 	 	 
	10.8. GOVERNING LAW 
	 	 	42	 

-iii-

 

TABLE OF CONTENTS
(continued)

	 	 	 	 	 
	 	 	PAGE	 
	10.9. NO ADVERSE INTERPRETATION OF OTHER AGREEMENTS 
	 	 	43	 
	 
	 	 	 	 
	10.10. NO RECOURSE AGAINST OTHERS 
	 	 	43	 
	 
	 	 	 	 
	10.11. SUCCESSORS 
	 	 	43	 
	 
	 	 	 	 
	10.12. MULTIPLE COUNTERPARTS 
	 	 	43	 
	 
	 	 	 	 
	10.13. TABLE OF CONTENTS, HEADINGS, ETC.
	 	 	43	 
	 
	 	 	 	 
	10.14. SEVERABILITY 
	 	 	43	 
	 
	 	 	 	 
	10.15. SECURITIES IN A FOREIGN CURRENCY OR IN EUROS 
	 	 	43	 
	 
	 	 	 	 
	10.16. JUDGMENT CURRENCY 
	 	 	44	 

-iv-

 

CROSS-REFERENCE TABLE

	 	 	 
	TIA SECTION	 	INDENTURE SECTION
	310(a)(1)(2)(5)
	 	7.10
	310(a)(3)(4)
	 	Inapplicable
	310(b)
	 	7.8; 7.10
	310(c)
	 	Inapplicable
	 
	 	 
	311(a)(b)
	 	7.11
	311(c)
	 	Inapplicable
	 
	 	 
	312(a)
	 	2.6
	312(b)(c)
	 	10.3
	 
	 	 
	313(a)(b)
	 	7.6
	313(c)
	 	7.6; 10.2
	313(d)
	 	7.6
	 
	 	 
	314(a)
	 	4.2; 4.4; 10.2
	314(b)
	 	N/A
	314(c)(1)(2)
	 	10.4; 10.5
	314(c)(3)
	 	Inapplicable
	314(d)
	 	Inapplicable
	314(e)
	 	10.5
	314(f)
	 	Inapplicable
	 
	 	 
	315(a)
	 	7.1, 7.2
	315(b)
	 	7.5; 10.2
	315(c)
	 	7.1
	315(d)
	 	7.1; 7.2
	315(e)
	 	6.11
	 
	 	 
	316(a)(last sentence)
	 	2.10
	316(a)(1)(A)
	 	6.5
	316(a)(1)(B)
	 	6.4
	316(a)(2)
	 	8.2
	316(b)
	 	6.7
	316(c)
	 	8.4
	 
	 	 
	317(a)(1)
	 	6.8
	317(a)(2)
	 	6.9
	317(b)
	 	2.5; 7.12
	318(a)
	 	10.1

 

			
	Note:	 	This Cross-Reference Table shall not, for any purpose, be deemed to be a part of the
Indenture.

-v-

 

     INDENTURE, dated as of                     ,           , by and between RXi Pharmaceuticals Corporation, a
Delaware corporation, as Issuer (the “Company”) and                                         , a                     
organized under the laws of                                         , as Trustee (the “Trustee”).

RECITALS OF THE COMPANY

     The Company has duly authorized the execution and delivery of this Indenture to provide for
the issuance from time to time of its debentures, notes or other evidences of indebtedness to be
issued in one or more series (the “Securities”), as herein provided, up to such principal amount as
may from time to time be authorized in or pursuant to one or more resolutions of the Board of
Directors or by supplemental indenture.

     All things necessary to make this Indenture a valid agreement of the Company in accordance
with its terms have been done, and the execution and delivery thereof have been in all respects
duly authorized by the parties hereto.

NOW, THEREFORE, THIS INDENTURE WITNESSETH:

     For and in consideration of the premises and the purchase of the Securities by the Holders
thereof, it is mutually agreed, for the equal and proportionate benefit of all Holders of the
Securities of a Series thereof, as follows:

ARTICLE 1

DEFINITIONS AND INCORPORATION BY REFERENCE

1.1. DEFINITIONS.

     “Affiliate” of any specified Person means any other Person which, directly or indirectly
through one or more intermediaries, controls, or is controlled by or is under common control with,
such specified Person. For the purposes of this definition, “control” (including, with correlative
meanings, the terms “controlling,” “controlled by” and “under common control with”), as used with
respect to any Person, means the possession, directly or indirectly, of the power to direct or
cause the direction of the management or policies of such Person, whether through the ownership of
voting securities, by agreement or otherwise.

     “Agent” means any Registrar, Paying Agent, co-registrar or agent for service of notices and
demands.

     “Board of Directors” means the Board of Directors of the Company or any committee duly
authorized to act therefor.

     “Board Resolution” means a copy of a resolution certified pursuant to an Officers’ Certificate
to have been duly adopted by the Board of Directors of the Company and to be in full force and
effect on the date of such certification which has been delivered to the Trustee.

 

 

     “Capital Stock” means, with respect to any Person, any and all shares or other equivalents
(however designated) of capital stock, partnership interests or any other participation, right or
other interest in the nature of an equity interest in such Person or any option, warrant or other
security convertible into any of the foregoing.

     “Company” means the party named as such in the first paragraph of this Indenture until a
successor replaces such party pursuant to Article 5 of this Indenture, and thereafter means the
successor and any other primary obligor on the Securities.

     “Company Order” means a written order signed in the name of the Company by two Officers, one
of whom must be its Chief Executive Officer or its Chief Financial Officer.

     “Company Request” means any written request signed in the name of the Company by its Chief
Executive Officer, its President, any Vice President, its Chief Financial Officer or its Treasurer
and attested to by its Secretary or any Assistant Secretary.

     “Corporate Trust Office” means the office of the Trustee at which at any particular time its
corporate trust business shall be principally administered.

     “Default” means any event that is, or that with the passing of time or giving of notice or
both would be, an Event of Default.

     “Depository” means, with respect to the Securities of any Series issuable or issued in whole
or in part in the form of one or more Global Securities, the Person designated as Depository for
such Series by the Company, which Depository shall be a clearing agency registered under the
Exchange Act, until a successor Depository shall have become such pursuant to the applicable
provisions of this Indenture, and thereafter “Depository” shall mean each Person who is then a
Depository hereunder, and if at any time there is more than one such Person, such Persons.

     “Dollars” means the currency of the United States of America.

     “Euro” means the single currency of participating member states of the economic and monetary
union as contemplated in the Treaty on European Union.

     “Exchange Act” means the Securities Exchange Act of 1934, as amended.

     “Foreign Currency” means any currency or currency unit issued by a government other than the
government of the United States of America.

     “Foreign Government Obligations” means, with respect to Securities that are denominated in a
Foreign Currency, (i) direct obligations of the government that issued or caused to be issued such
currency for the payment of which obligations its full faith and credit is pledged or (ii)
obligations of a Person controlled or supervised by, or acting as an agency or instrumentality of,
such government, the timely payment of which is unconditionally guaranteed as a full faith and
credit obligation by such government, which, in either case under clauses (i) and (ii), are not
callable or redeemable at the option of the issuer thereof.

-2-

 

     “GAAP” means generally accepted accounting principles consistently applied as in effect in the
United States of America from time to time.

     “Global Security” or “Global Securities” means a Security or Securities, as the case may be,
in the form established pursuant to Section 2.2, evidencing all or part of a Series of Securities
issued to the Depository for such Series or its nominee, and registered in the name of such
Depository or nominee, and bearing the legend set forth in Section 2.15(c) (or such other legend(s)
as may be applied to such Securities in accordance with Section 2.2(24)).

     “Holder” or “Securityholder” means the Person in whose name a Security is registered on the
Registrar’s books.

     “Indebtedness” means (without duplication), with respect to any Person, any indebtedness at
any time outstanding, secured or unsecured, contingent or otherwise, which is for borrowed money
(whether or not the recourse of the lender is to the whole of the assets of such Person or only to
a portion thereof), or evidenced by bonds, notes, debentures or similar instruments, or
representing the balance deferred and unpaid of the purchase price of any property (excluding any
balances that constitute accounts payable or trade payables, and other accrued liabilities arising
in the ordinary course of business), if and to the extent any of the foregoing indebtedness would
appear as a liability upon a balance sheet of such Person prepared in accordance with GAAP.

     “Indenture” means this Indenture as amended, restated or supplemented from time to time.

     “Interest Payment Date,” when used with respect to any Security, means the Stated Maturity of
an installment of interest on such Security.

     “Lien” means, with respect to any property or assets of any Person, any mortgage or deed of
trust, pledge, hypothecation, assignment, deposit arrangement, security interest, lien, charge,
easement, encumbrance, preference, priority or other security agreement or preferential arrangement
of any kind or nature whatsoever on or with respect to such property or assets (including, without
limitation, any capitalized lease obligation, conditional sales or other title retention agreement
having substantially the same economic effect as any of the foregoing).

     “Maturity,” when used with respect to any Security, means the date on which the principal of
such Security, or an installment of principal, becomes due and payable as therein or herein
provided, whether at the Stated Maturity or by declaration of acceleration, call for redemption,
notice of option to elect payment or otherwise.

     “Officer” means the Chief Executive Officer, the President, any Vice President, the Chief
Financial Officer, the Treasurer or the Secretary of the Company, or any other officer designated
by the Board of Directors, as the case may be.

     “Officers’ Certificate” means, with respect to any Person, a certificate signed by the
Chairman, Chief Executive Officer, President or any Senior or Executive Vice President and the
Chief Financial Officer or any Treasurer of such Person, that shall comply with applicable
provisions of this Indenture.

-3-

 

     “Opinion of Counsel” means a written opinion from legal counsel, which counsel is reasonably
acceptable to the Trustee. The counsel may be an employee of or counsel to the Company.

     “Person” means any individual, corporation, limited liability company, partnership, joint
venture, association, joint-stock company, trust, unincorporated organization or government
(including any agency or political subdivision thereof).

     “Redemption Date,” when used with respect to any Security to be redeemed, means the date fixed
for such redemption pursuant to this Indenture.

     “Responsible Officer,” when used with respect to the Trustee, means any officer within the
corporate trust department or division of the Trustee (or any successor group of the Trustee) or
any other officer of the Trustee customarily performing functions similar to those performed by any
of the above designated officers, and also means, with respect to a particular corporate trust
matter, any other officer to whom such matter is referred because of his knowledge of and
familiarity with the particular subject.

     “SEC” means the United States Securities and Exchange Commission as constituted from time to
time, or any successor performing substantially the same functions.

     “Securities” means the securities that are issued under this Indenture, as amended or
supplemented from time to time pursuant to this Indenture.

     “Securities Act” means the Securities Act of 1933, as amended.

     “Series” or “Series of Securities” means each series of debentures, notes or other debt
instruments of the Company created pursuant to Sections 2.1 and 2.2.

     “Significant Subsidiary” means (i) any direct or indirect Subsidiary of the Company that would
be a “significant subsidiary” as defined in Article 1, Rule 1-02 of Regulation S-X, promulgated
pursuant to the Securities Act, as such regulation is in effect on the date hereof, or (ii) any
group of direct or indirect Subsidiaries of the Company that, taken together as a group, would be a
“significant subsidiary” as defined in Article 1, Rule 1-02 of Regulation S-X, promulgated pursuant
to the Securities Act, as such regulation is in effect on the date hereof.

     “Stated Maturity,” when used with respect to any Security or any installment of principal
thereof or interest thereon, means the date specified in such Security as the fixed date on which
the principal of such Security, or such installment of principal or interest, is due and payable,
and when used with respect to any other Indebtedness, means the date specified in the instrument
governing such Indebtedness as the fixed date on which the principal of such Indebtedness, or any
installment of interest thereon, is due and payable.

     “Subsidiary” of any specified Person means any corporation, limited liability company,
partnership, joint venture, association or other business entity, whether now existing or hereafter
organized or acquired, (i) in the case of a corporation, of which more than 50% of the total voting
power of the Capital Stock entitled (without regard to the occurrence of any contingency) to vote
in the election of directors thereof is held, directly or indirectly, by such Person or any of

-4-

 

its Subsidiaries; or (ii) in the case of a partnership, joint venture, association or other
business entity, with respect to which such Person or any of its Subsidiaries has the power to
direct or cause the direction of the management and policies of such entity by contract or
otherwise, or if in accordance with GAAP such entity is consolidated with such Person for financial
statement purposes.

     “TIA” means the Trust Indenture Act of 1939 (15 U.S. Code Section 77aaa-77bbbb) as in effect
on the date of this Indenture (except as provided in Section 8.3).

     “Trustee” means the party named as such in this Indenture until a successor replaces it
pursuant to this Indenture, and thereafter means the successor, and if at any time there is more
than one such Person, “Trustee” as used with respect to the Securities of any Series shall mean the
Trustee with respect to Securities of that Series.

     “U.S. Government Obligations” means direct non-callable obligations of, or non-callable
obligations guaranteed by, the United States of America for the payment of which obligation or
guarantee the full faith and credit of the United States of America is pledged.

1.2. OTHER DEFINITIONS.

     The definitions of the following terms may be found in the sections indicated as follows:

	 	 	 
	TERM	 	DEFINED IN SECTION
	“Bankruptcy Law”
	 	6.1
	 
	 	 
	“Business Day”
	 	10.7
	 
	 	 
	“Covenant Defeasance”
	 	9.3
	 
	 	 
	“Custodian”
	 	6.1
	 
	 	 
	“Event of Default”
	 	6.1
	 
	 	 
	“Journal”
	 	10.15
	 
	 	 
	“Judgment Currency”
	 	10.16
	 
	 	 
	“Legal Defeasance”
	 	9.2
	 
	 	 
	“Legal Holiday”
	 	10.7
	 
	 	 
	“Market Exchange Rate”
	 	10.15
	 
	 	 
	“New York Paying Agent”
	 	2.4
	 
	 	 
	“Paying Agent”
	 	2.4
	 
	 	 
	“Place of Payment”
	 	10.7
	 
	 	 
	“Registrar”
	 	2.4

-5-

 

	 	 	 
	TERM	 	DEFINED IN SECTION
	“Required Currency”
	 	10.16
	 
	 	 
	“Service Agent”
	 	2.4

1.3. INCORPORATION BY REFERENCE OF TRUST INDENTURE ACT.

     Whenever this Indenture refers to a provision of the TIA, the portion of such provision
required to be incorporated herein in order for this Indenture to be qualified under the TIA is
incorporated by reference in and made a part of this Indenture. The following TIA terms used in
this Indenture have the following meanings:

     “Commission” means the SEC.

     “indenture securities” means the Securities.

     “indenture securityholder” means a Holder or Securityholder.

     “indenture to be qualified” means this Indenture.

     “indenture trustee” or “institutional trustee” means the Trustee.

     “obligor on the indenture securities” means the Company.

     All other terms used in this Indenture that are defined by the TIA, defined in the TIA by
reference to another statute or defined by SEC rule have the meanings therein assigned to them.

1.4. RULES OF CONSTRUCTION.

     Unless the context otherwise requires:

          (1) a term has the meaning assigned to it herein, whether defined expressly or by reference;

          (2) an accounting term not otherwise defined has the meaning assigned to it in accordance with
GAAP;

          (3) “or” is not exclusive;

          (4) words in the singular include the plural, and in the plural include the singular;

          (5) words used herein implying any gender shall apply to each gender; and

          (6) the words “herein”, “hereof” and “hereunder” and other words of similar import refer to
this Indenture as a whole and not to any particular Article, Section or other subdivision.

-6-

 

ARTICLE 2

THE SECURITIES

2.1. ISSUABLE IN SERIES.

     The aggregate principal amount of Securities that may be authenticated and delivered under
this Indenture is $30,000,000. The Securities may be issued in one or more Series. All Securities
of a Series shall be identical except as may be set forth in a Board Resolution, a supplemental
indenture or an Officers’ Certificate detailing the adoption of the terms thereof pursuant to the
authority granted under a Board Resolution. In the case of Securities of a Series to be issued
from time to time, the Board Resolution, Officers’ Certificate or supplemental indenture may
provide for the method by which specified terms (such as interest rate, Stated Maturity, record
date or date from which interest shall accrue) are to be determined. Securities may differ between
Series in respect of any matters, PROVIDED, that all Series of Securities shall be equally and
ratably entitled to the benefits of the Indenture.

2.2. ESTABLISHMENT OF TERMS OF SERIES OF SECURITIES.

     At or prior to the issuance of any Securities within a Series, the following shall be
established (as to the Series generally, in the case of Subsection 2.2(1) and either as to such
Securities within the Series or as to the Series generally in the case of Subsections 2.2(2)
through 2.2(24)) by a Board Resolution, a supplemental indenture or an Officers’ Certificate, in
each case, pursuant to authority granted under a Board Resolution:

          (1) the title of the Series (which shall distinguish the Securities of that particular Series
from the Securities of any other Series);

          (2) any limit upon the aggregate principal amount of the Securities of the Series which may be
authenticated and delivered under this Indenture (except for Securities authenticated and delivered
upon registration of transfer of, or in exchange for, or in lieu of, other Securities of the Series
pursuant to Section 2.7, 2.8, 2.11, 3.6 or 8.5);

          (3) the price or prices (expressed as a percentage of the principal amount thereof) at which
the Securities of the Series will be issued;

          (4) the date or dates on which the principal of the Securities of the Series is payable;

          (5) the rate or rates (which may be fixed or variable) per annum or, if applicable, the method
used to determine such rate or rates (including, but not limited to, any commodity, commodity
index, stock exchange index or financial index) at which the Securities of the Series shall bear
interest, if any, the date or dates from which such interest, if any, shall accrue, the date or
dates on which such interest, if any, shall commence and be payable and any regular record date for
the interest payable on any Interest Payment Date;

-7-

 

          (6) the place or places where the principal of, and interest and premium, if any, on, the
Securities of the Series shall be payable, or the method of such payment, if by wire transfer, mail
or other means;

          (7) if applicable, the period or periods within which, the price or prices at which and the
terms and conditions upon which the Securities of the Series may be redeemed, in whole or in part,
at the option of the Company;

          (8) the obligation, if any, of the Company to redeem or purchase the Securities of the Series
pursuant to any sinking fund or analogous provisions or at the option of a Holder thereof, and the
period or periods within which, the price or prices at which and the terms and conditions upon
which Securities of the Series shall be redeemed or purchased, in whole or in part, pursuant to
such obligation;

          (9) the dates, if any, on which and the price or prices at which the Securities of the Series
will be repurchased by the Company at the option of the Holders thereof, and other detailed terms
and provisions of such repurchase obligations;

          (10) if other than denominations of $1,000 and any integral multiple thereof, the
denominations in which the Securities of the Series shall be issuable;

          (11) the forms of the Securities of the Series in bearer (if to be issued outside of the
United States of America) or fully registered form (and, if in fully registered form, whether the
Securities will be issuable as Global Securities);

          (12) if other than the principal amount thereof, the portion of the principal amount of the
Securities of the Series that shall be payable upon declaration of acceleration of the Maturity
thereof pursuant to Section 6.2;

          (13) the currency of denomination of the Securities of the Series, which may be Dollars or any
Foreign Currency, including, but not limited to, the Euro, and, if such currency of denomination is
a composite currency other than the Euro, the agency or organization, if any, responsible for
overseeing such composite currency;

          (14) the designation of the currency, currencies or currency units in which payment of the
principal of, and interest and premium, if any, on, the Securities of the Series will be made;

          (15) if payments of principal of, or interest or premium, if any, on, the Securities of the
Series are to be made in one or more currencies or currency units other than that or those in which
such Securities are denominated, the manner in which the exchange rate with respect to such
payments will be determined;

          (16) the manner in which the amounts of payment of principal of, or interest and premium, if
any, on, the Securities of the Series will be determined, if such amounts may be determined by
reference to an index based on a currency or currencies or by reference to a commodity, commodity
index, stock exchange index or financial index;

-8-

 

          (17) the provisions, if any, relating to any collateral provided for the Securities of the
Series;

          (18) any addition to or change in the covenants set forth in Articles 4 or 5 that applies to
Securities of the Series;

          (19) any addition to or change in the Events of Default which applies to any Securities of the
Series, and any change in the right of the Trustee or the requisite Holders of such Securities to
declare the principal amount thereof due and payable pursuant to Section 6.2;

          (20) the terms and conditions, if any, for conversion of the Securities into or exchange of
the Securities for shares of common stock or preferred stock of the Company that apply to
Securities of the Series;

          (21) any depositories, interest rate calculation agents, exchange rate calculation agents or
other agents with respect to Securities of such Series if other than those appointed herein;

          (22) the terms and conditions, if any, upon which the Securities shall be subordinated in
right of payment to other Indebtedness of the Company;

          (23) if applicable, that the Securities of the Series, in whole or any specified part, shall
be defeasible pursuant to Article 9; and

          (24) any other terms of the Securities of the Series (which terms shall not be inconsistent
with the provisions of this Indenture, except as permitted by Section 8.1, but which may modify or
delete any provision of this Indenture insofar as it applies to such Series).

     All Securities of any one Series need not be issued at the same time, and may be issued from
time to time, consistent with the terms of this Indenture, if so provided by or pursuant to the
Board Resolution, supplemental indenture or Officers’ Certificate referred to above, however, the
authorized principal amount of any Series may not be increased to provide for issuances of
additional Securities of such Series, unless otherwise provided in such Board Resolution,
supplemental indenture or Officers’ Certificate.

2.3. EXECUTION AND AUTHENTICATION.

     The Securities shall be executed on behalf of the Company by two Officers of the Company or an
Officer and an Assistant Secretary of the Company. Each such signature may be either manual or
facsimile. The Company’s seal may be impressed, affixed, imprinted or reproduced on the Securities
and may be in facsimile form.

     If an Officer whose signature is on a Security no longer holds that office at the time the
Security is authenticated, the Security shall nevertheless be valid.

     A Security shall not be valid until authenticated by the manual signature of the Trustee or an
authenticating agent. The signature shall be conclusive evidence that the Security has been
authenticated under this Indenture. The Trustee shall at any time, and from time to time,

-9-

 

authenticate Securities for original issue in the principal amount provided in the Board
Resolution, supplemental indenture hereto or Officers’ Certificate, upon receipt by the Trustee of
a Company Order. Such Company Order may authorize authentication and delivery pursuant to oral or
electronic instructions from the Company or its duly authorized agent or agents, which oral
instructions shall be promptly confirmed in writing. Each Security shall be dated the date of its
authentication.

     The aggregate principal amount of Securities of any Series outstanding at any time may not
exceed any limit upon the maximum principal amount for such Series set forth in the Board
Resolution, supplemental indenture hereto or Officers’ Certificate delivered pursuant to Section
2.2, except as provided in Section 2.8.

     Prior to the issuance of Securities of any Series, the Trustee shall have received and
(subject to Section 7.1) shall be fully protected in relying on: (a) the Board Resolution,
supplemental indenture hereto or Officers’ Certificate establishing the form of the Securities of
that Series or of Securities within that Series and the terms of the Securities of that Series or
of Securities within that Series, (b) an Officers’ Certificate complying with Section 10.4, and (c)
an Opinion of Counsel complying with Section 10.4.

     The Trustee shall have the right to decline to authenticate and deliver any Securities of any
Series: (a) if the Trustee, being advised in writing by outside counsel, determines that such
action may not lawfully be taken; or (b) if the Trustee in good faith by its board of directors or
trustees, executive committee or a trust committee of directors and/or vice-presidents shall
reasonably determine that such action would expose the Trustee to personal liability, or cause it
to have a conflict of interest with respect to Holders of any then outstanding Series of
Securities.

     The Trustee may appoint an authenticating agent acceptable to the Company to authenticate
Securities. An authenticating agent may authenticate Securities whenever the Trustee may do so.
Any appointment shall be evidenced by an instrument signed by an authorized officer of the Trustee,
a copy of which shall be furnished to the Company. Each reference in this Indenture to
authentication by the Trustee includes authentication by such agent. An authenticating agent has
the same rights as an Agent to deal with the Company or an Affiliate of the Company.

2.4. REGISTRAR AND PAYING AGENT.

     The Company shall maintain in each Place of Payment for any Series of Securities (i) an office
or agency where such Securities may be presented for registration of transfer or for exchange
(“Registrar”), (ii) an office or agency where such Securities may be presented for payment (“Paying
Agent”) (PROVIDED that the Company shall at all times maintain a Paying Agent in the Borough of
Manhattan, City of New York, State of New York (the “New York Paying Agent”), and PROVIDED,
FURTHER, that at the option of the Company payment of interest may be made by check mailed to the
address of the Person entitled thereto as such address shall appear in the register for the
Securities maintained by the Registrar), and (iii) an office or agency where notices and demands to
or upon the Company in respect of the Securities and this Indenture may be served (“Service
Agent”). The Registrar shall keep a register of the Securities and of their transfer and exchange.
The Company may have one or more co-registrars

-10-

 

and one or more additional paying agents. The Company shall give prompt written notice to the
Trustee of the location, and any change in the location, of such office or agency. If at any time
the Company shall fail to maintain any such required office, or to furnish the Trustee with the
address thereof, such presentations, surrenders, notices and demands may be made or served at the
address of the Trustee as set forth in Section 10.2. If the Company acts as Paying Agent, it shall
segregate the money held by it for the payment of principal of, and interest and premium, if any,
on, the Securities and hold it as a separate trust fund. The Company may change any Paying Agent,
Registrar, co-registrar or any other Agent without notice to any Securityholder.

     The Company may also from time to time designate one or more other offices or agencies where
the Securities may be presented or surrendered for any or all such purposes, and may from time to
time rescind such designations; PROVIDED, HOWEVER, that no such designation or rescission shall in
any manner relieve the Company of its obligation to maintain an office or agency in each Place of
Payment for Securities of any Series for such purposes. The Company hereby initially designates
the Corporate Trust Office of the Trustee as such office of the
Company. The Company shall give
prompt written notice to the Trustee of such designation or rescission, and of any change in the
location of any such other office or agency.

     The Company shall enter into an appropriate agency agreement with any Registrar or Paying
Agent not a party to this Indenture. The agreement shall implement the provisions of this
Indenture that relate to such Agent. The Company shall notify the Trustee of the name and address
of any such Agent. If the Company fails to maintain a Registrar or Paying Agent, or agent for
service of notices and demands, or fails to give the foregoing notice, the Trustee shall act as
such. The Company hereby appoints the Trustee as the initial Registrar, Paying Agent and Service
Agent for each Series unless another Registrar, Paying Agent or Service Agent, as the case may be,
is appointed prior to the time Securities of that Series are first issued. The Company designates
                                        , as the New York Paying Agent, with offices at                      
                  .

2.5. PAYING AGENT TO HOLD ASSETS IN TRUST.

     The Trustee as Paying Agent shall, and the Company shall require each Paying Agent other than
the Trustee to agree in writing that each Paying Agent shall, hold in trust for the benefit of the
Holders of any Series of Securities or the Trustee all assets held by the Paying Agent for the
payment of principal of, or interest or premium, if any, on, such Series of Securities (whether
such assets have been distributed to it by the Company or any other obligor on such Series of
Securities), and the Company and the Paying Agent shall notify the Trustee in writing of any
Default by the Company (or any other obligor on such Series of Securities) in making any such
payment. The Company at any time may require a Paying Agent to distribute all assets held by it to
the Trustee and account for any assets disbursed, and the Trustee may, at any time during the
continuance of any payment default with respect to any Series of Securities, upon written request
to a Paying Agent, require such Paying Agent to distribute all assets held by it to the Trustee and
to account for any assets distributed. Upon distribution to the Trustee of all assets that shall
have been delivered by the Company to the Paying Agent, the Paying Agent shall have no further
liability for such assets.

-11-

 

2.6. SECURITYHOLDER LISTS.

     The Trustee shall preserve in as current a form as is reasonably practicable the most recent
list available to it of the names and addresses of Securityholders of each Series of Securities.
If the Trustee is not the Registrar, the Company shall furnish to the Trustee as of each regular
record date for the payment of interest on the Securities of a Series and before each related
Interest Payment Date, and at such other times as the Trustee may request in writing, a list in
such form and as of such date as the Trustee may reasonably require of the names and addresses of
Securityholders of each Series of Securities.

2.7. TRANSFER AND EXCHANGE.

     When Securities of a Series are presented to the Registrar with a request to register the
transfer thereof, the Registrar shall register the transfer as requested if the requirements of
applicable law are met, and when such Securities of a Series are presented to the Registrar with a
request to exchange them for an equal principal amount of other authorized denominations of
Securities of the same Series, the Registrar shall make the exchange as requested. To permit
transfers and exchanges, upon surrender of any Security for registration of transfer at the office
or agency maintained pursuant to Section 2.4, the Company shall execute and the Trustee shall
authenticate Securities at the Registrar’s request.

     If Securities are issued as Global Securities, the provisions of Section 2.15 shall apply.

     All Securities issued upon any registration of transfer or exchange of Securities shall be the
valid obligations of the Company, evidencing the same debt, and entitled to the same benefits under
this Indenture, as the Securities surrendered upon such registration of transfer or exchange.

     Every Security presented or surrendered for registration of transfer or for exchange shall (if
so required by the Company or the Registrar or a co-registrar) be duly endorsed, or be accompanied
by a written instrument of transfer in form satisfactory to the Company and the Registrar or a
co-registrar, duly executed by the Holder thereof or his attorney duly authorized in writing.

     Any exchange or transfer shall be without charge, except that the Company may require payment
by the Holder of a sum sufficient to cover any tax or other governmental charge that may be imposed
in relation to a transfer or exchange, but this provision shall not apply to any exchange pursuant
to Section 2.11, 3.6 or 8.5. The Trustee shall not be required to register transfers of Securities
of any Series, or to exchange Securities of any Series, for a period of 15 days before the record
date for selection for redemption of such Securities. The Trustee shall not be required to
exchange or register transfers of Securities of any Series called or being called for redemption in
whole or in part, except the unredeemed portion of such Security being redeemed in part.

2.8. REPLACEMENT SECURITIES.

     If a mutilated Security is surrendered to the Trustee, or if the Holder of a Security presents
evidence to the satisfaction of the Company and the Trustee that the Security has been lost,
destroyed or wrongfully taken, the Company shall issue and the Trustee shall authenticate a

-12-

 

replacement Security of the same Series and of like tenor and principal amount and bearing a
number not contemporaneously outstanding. An indemnity bond may be required by the Company or the
Trustee that is sufficient in the reasonable judgment of the Company or the Trustee, as the case
may be, to protect the Company, the Trustee or any Agent from any loss which any of them may suffer
if a Security is replaced. The Company may charge such Holder for the Company’s out-of-pocket
expenses in replacing a Security, including the fees and expenses of the Trustee. Every
replacement Security shall constitute an original additional obligation of the Company, whether or
not the destroyed, lost or stolen Security shall be at any time enforceable by anyone, and shall be
entitled to all the benefits of this Indenture equally and proportionately with any and all other
Securities of that Series duly issued hereunder.

2.9. OUTSTANDING SECURITIES.

     Securities outstanding at any time are all Securities authenticated by the Trustee, except for
those canceled by it, those delivered to it for cancellation and those described in this Section
2.9 as not outstanding.

     If a Security is replaced pursuant to Section 2.8 (other than a mutilated Security surrendered
for replacement), it ceases to be outstanding until the Company and the Trustee receive proof
satisfactory to each of them that the replaced Security is held by a bona fide purchaser. A
mutilated Security ceases to be outstanding upon surrender of such Security and replacement thereof
pursuant to Section 2.8.

     If a Paying Agent holds on a Redemption Date or the Stated Maturity money sufficient to pay
the principal of, premium, if any, and accrued interest on, Securities payable on that date, and is
not prohibited from paying such money to the Holders thereof pursuant to the terms of this
Indenture (PROVIDED, that if such Securities are to be redeemed, notice of such redemption has been
duly given pursuant to this Indenture or provision therefor satisfactory to the Trustee has been
made), then on and after that date such Securities cease to be outstanding and interest on them
ceases to accrue.

     A Security does not cease to be outstanding solely because the Company or an Affiliate holds
the Security.

2.10. WHEN TREASURY SECURITIES DISREGARDED; DETERMINATION OF HOLDERS’ ACTION.

     In determining whether the Holders of the required aggregate principal amount of the
Securities of any Series have concurred in any direction, waiver or consent, the Securities of any
Series owned by the Company or any other obligor on such Securities, or by any Affiliate of any of
them, shall be disregarded, except that for the purposes of determining whether the Trustee shall
be protected in relying on any such direction, waiver or consent, only Securities of such Series
which the Trustee actually knows are so owned shall be so disregarded. Securities of such Series
so owned which have been pledged in good faith shall not be disregarded if the pledgee establishes
to the satisfaction of the Trustee the pledgee’s right so to act with respect to the Securities of
such Series and that the pledgee is not the Company or any other obligor on the Securities of such
Series, or an Affiliate of any of them.

-13-

 

2.11. TEMPORARY SECURITIES.

     Until definitive Securities are ready for delivery, the Company may prepare and execute, and
the Trustee shall authenticate, temporary Securities. Temporary Securities shall be substantially
in the form, and shall carry all rights, of definitive Securities, but may have variations that the
Company considers appropriate for temporary Securities. Without unreasonable delay, the Company
shall prepare and execute, and the Trustee shall authenticate, definitive Securities in exchange
for temporary Securities without charge to the Holder.

2.12. CANCELLATION.

     All Securities surrendered for payment, redemption or registration of transfer or exchange, or
for credit against any sinking fund payment, shall, if surrendered to any Person other than the
Trustee, be delivered to the Trustee for cancellation. The Company may at any time deliver to the
Trustee for cancellation any Securities previously authenticated and delivered hereunder which the
Company may have acquired in any manner whatsoever, and may deliver to the Trustee (or to any other
Person for delivery to the Trustee) for cancellation any Securities previously authenticated
hereunder which the Company has not issued and sold. The Registrar and the Paying Agent shall
forward to the Trustee any Securities surrendered to them for transfer, exchange or payment. The
Trustee or, at the direction of the Trustee, the Registrar or the Paying Agent, and no one else,
shall cancel, and at the written request of the Company shall dispose of, all Securities
surrendered for transfer, exchange, payment or cancellation. If the Company shall acquire any of
the Securities, such acquisition shall not operate as a redemption or satisfaction of the
Indebtedness represented by such Securities unless and until the same are surrendered to the
Trustee for cancellation pursuant to this Section 2.12. No Securities shall be authenticated in
lieu of or in exchange for any Securities cancelled as provided in this Section 2.12, except as
expressly permitted by this Indenture.

2.13. PAYMENT OF INTEREST; DEFAULTED INTEREST; COMPUTATION OF INTEREST.

     Except as otherwise provided as contemplated by Section 2.2 with respect to any Series of
Securities, interest on any Security which is payable, and is punctually paid or duly provided for,
on any Interest Payment Date shall be paid to the Person in whose name that Security is registered
at the close of business on the regular record date for such interest, as provided in the Board
Resolution, supplemental indenture hereto or Officers’ Certificate establishing the terms of such
Series.

     If the Company defaults in a payment of interest on the Securities, it shall pay the defaulted
amounts, plus any interest payable on defaulted amounts pursuant to Section 4.1, to the Persons who
are Securityholders on a subsequent special record date, which date shall be the 15th day next
preceding the date fixed by the Company for the payment of defaulted interest, or the next
succeeding Business Day if such date is not a Business Day. At least 15 days before the special
record date, the Company shall mail or cause to be mailed to each Securityholder, with a copy to
the Trustee, a notice that states the special record date, the payment date and the amount of
defaulted interest, and interest payable on such defaulted interest, if any, to be paid.

-14-

 

     Except as otherwise specified as contemplated by Section 2.2 for Securities of any Series,
interest on the Securities of each Series shall be computed on the basis of a 360-day year of
twelve 30-day months.

2.14. CUSIP NUMBER.

     The Company in issuing the Securities may use one or more “CUSIP” numbers, and, if the Company
does so, the Trustee shall use the CUSIP number(s) in notices of redemption or exchange as a
convenience to Holders, PROVIDED, that any such notice may state that no representation is made as
to the correctness or accuracy of the CUSIP number(s) printed in the notice or on the Securities,
and that reliance may be placed only on the other identification numbers printed on the Securities,
and that any such redemption or exchange shall not be affected by any defect in or omission of any
such numbers.

2.15. PROVISIONS FOR GLOBAL SECURITIES.

     (a) A Board Resolution, a supplemental indenture hereto or an Officers’ Certificate shall
establish whether the Securities of a Series shall be issued in whole or in part in the form of one
or more Global Securities, and the Depository for such Global Securities or Securities.

     (b) Notwithstanding any provisions to the contrary contained in Section 2.7 and in addition
thereto, if, and only if the Depository (i) at any time is unwilling or unable to continue as
Depository for such Global Security or ceases to be a clearing agency registered under the Exchange
Act and (ii) a successor Depository is not appointed by the Company within 90 days after the date
the Company is so informed in writing or becomes aware of the same, the Company promptly will
execute and deliver to the Trustee definitive Securities, and the Trustee, upon receipt of a
Company Request for the authentication and delivery of such definitive Securities (which the
Company will promptly execute and deliver to the Trustee) and an Officers’ Certificate to the
effect that such Global Security shall be so exchangeable, will authenticate and deliver definitive
Securities, without charge, registered in such names and in such authorized denominations as the
Depository shall direct in writing (pursuant to instructions from its direct and indirect
participants or otherwise) in an aggregate principal amount equal to the principal amount of the
Global Security with like tenor and terms. Upon the exchange of a Global Security for definitive
Securities, such Global Security shall be canceled by the Trustee. Unless and until it is
exchanged in whole or in part for definitive Securities, as provided in this Section 2.15(b), a
Global Security may not be transferred except as a whole by the Depository with respect to such
Global Security to a nominee of such Depository, by a nominee of such Depository to such Depository
or another nominee of such Depository or by the Depository or any such nominee to a successor
Depository or a nominee of such a successor Depository.

     (c) Any Global Security issued hereunder shall bear a legend in substantially the following
form:

“This Security is a Global Security within the meaning of the
Indenture hereinafter referred to, and is registered in the name of
the Depository or a nominee of the Depository. This Security is
exchangeable for Securities registered in the name of a Person

-15-

 

other than the Depository or its nominee only in the limited
circumstances described in the Indenture, and may not be transferred
except as a whole by the Depository to a nominee of the Depository,
by a nominee of the Depository to the Depository or another nominee
of the Depository or by the Depository or any such nominee to a
successor Depository or a nominee of such a successor Depository.”

     (d) The Depository, as a Holder, may appoint agents and otherwise authorize participants to
give or take any request, demand, authorization, direction, notice, consent, waiver or other action
which a Holder is entitled to give or take under the Indenture.

     (e) Notwithstanding the other provisions of this Indenture, unless otherwise specified as
contemplated by Section 2.2, payment of the principal of, and interest and premium, if any, on, any
Global Security shall be made to the Depository or its nominee in its capacity as the Holder
thereof.

     (f) Except as provided in Section 2.15(e) above, the Company, the Trustee and any Agent shall
treat a Person as the Holder of such principal amount of outstanding Securities of any Series
represented by a Global Security as shall be specified in a written statement of the Depository
(which may be in the form of a participants’ list for such Series) with respect to such Global
Security, for purposes of obtaining any consents, declarations, waivers or directions required to
be given by the Holders pursuant to this Indenture, PROVIDED, that until the Trustee is so provided
with a written statement, it may treat the Depository or any other Person in whose name a Global
Security is registered as the owner of such Global Security for the purpose of receiving payment of
the principal of, and any premium and (subject to Section 2.13) any interest on, such Global
Security and for all other purposes whatsoever, and none of the Company, the Trustee or any agent
of the Company or the Trustee shall be affected by notice to the contrary.

2.16. PERSONS DEEMED OWNERS.

     Prior to due presentment of a Security for registration of transfer, the Company, the Trustee,
the Registrar and any agent of the Company, the Registrar or the Trustee may treat the Person in
whose name such Security is registered as the owner of such Security for the purpose of receiving
payment of the principal of, and any premium and (subject to Section 2.13) any interest on, such
Security and for all other purposes whatsoever, and none of the Company, the Trustee, the Registrar
or any agent of the Company, the Trustee or the Registrar shall be affected by notice to the
contrary.

ARTICLE 3

REDEMPTION

3.1. NOTICES TO TRUSTEE.

     The Company may, with respect to any Series of Securities, reserve the right to redeem and pay
the Series of Securities, or may covenant to redeem and pay the Series of Securities or

-16-

 

any part thereof, prior to the Stated Maturity thereof at such time and on such terms as
provided for in such Securities or the related Board Resolution, supplemental indenture or
Officers’ Certificate. If a Series of Securities is redeemable and the Company elects to redeem
all or part of such Series of Securities, it shall notify the Trustee of the Redemption Date and
the principal amount of Securities to be redeemed at least 45 days (unless a shorter notice shall
be satisfactory to the Trustee) before the Redemption Date. Any such notice may be canceled at any
time prior to notice of such redemption being mailed to any Holder, and shall thereby be void and
of no effect.

3.2. SELECTION BY TRUSTEE OF SECURITIES TO BE REDEEMED.

     Unless otherwise indicated for a particular Series of Securities by a Board Resolution, a
supplemental indenture or an Officers’ Certificate, if fewer than all of the Securities of a Series
are to be redeemed, the Trustee shall select the Securities of a Series to be redeemed pro rata, by
lot or by any other method that the Trustee considers fair and appropriate (unless the Company
specifically directs the Trustee otherwise) and, if such Securities are listed on any securities
exchange, by a method that complies with the requirements of such exchange.

     The Trustee shall make the selection from Securities of a Series outstanding and not
previously called for redemption, and shall promptly notify the Company in writing of the
Securities selected for redemption and, in the case of any Security selected for partial
redemption, the principal amount thereof to be redeemed at least 35 but not more than 60 days
before the Redemption Date. Securities of a Series in denominations of $1,000 may be redeemed only
in whole. The Trustee may select for redemption portions of the principal of Securities of a
Series that have denominations larger than $1,000. Securities of a Series and portions of them it
selects shall be in amounts of $1,000 or, with respect to Securities of any Series issuable in
other denominations pursuant to Section 2.2(10), the minimum principal denomination for each Series
and integral multiples thereof. Provisions of this Indenture that apply to Securities called for
redemption also apply to portions of Securities called for redemption.

3.3. NOTICE OF REDEMPTION.

     Unless otherwise indicated for a particular Series by Board Resolution, a supplemental
indenture hereto or an Officers’ Certificate, at least 30 days, and no more than 60 days, before a
Redemption Date, the Company shall mail, or cause to be mailed, a notice of redemption by
first-class mail to each Holder of Securities to be redeemed at his or her last address as the same
appears on the registry books maintained by the Registrar. The notice shall identify the
Securities to be redeemed and shall state:

          (1) the Redemption Date;

          (2) the redemption price, and that such redemption price shall become due and payable on the
Redemption Date;

          (3) if any Security of a Series is being redeemed in part, the portion of the principal amount
of such Security of a Series to be redeemed and that, after the Redemption

-17-

 

Date and upon surrender of such Security of a Series, a new Security or Securities in
principal amount equal to the unredeemed portion will be issued;

          (4) the name and address of the Paying Agent;

          (5) that Securities of a Series called for redemption must be surrendered to the Paying Agent
to collect the redemption price, and the place or places where each such Security is to be
surrendered for such payment;

          (6) that, unless the Company defaults in making the redemption payment, interest on the
Securities of a Series called for redemption ceases to accrue on the Redemption Date, and the only
remaining right of the Holders of such Securities is to receive payment of the redemption price
upon surrender to the Paying Agent of the Securities redeemed;

          (7) if fewer than all of the Securities of a Series are to be redeemed, the identification of
the particular Securities of a Series (or portion thereof) to be redeemed, as well as the aggregate
principal amount of Securities of a Series to be redeemed and the aggregate principal amount of
Securities of a Series to be outstanding after such partial redemption.

          (8) the CUSIP number, if any, printed on the Securities being redeemed; and

          (9) that no representation is made as to the correctness or accuracy of the CUSIP number, if
any, listed in such notice or printed on the Securities.

     At the Company’s request, the Trustee shall give the notice of redemption in the Company’s
name and at the Company’s sole expense.

3.4. EFFECT OF NOTICE OF REDEMPTION.

     Once the notice of redemption described in Section 3.3 is mailed, Securities of a Series
called for redemption become due and payable on the Redemption Date and at the redemption price,
plus interest, if any, accrued to the Redemption Date. Upon surrender to the Trustee or Paying
Agent, such Securities of a Series shall be paid at the redemption price, plus accrued interest, if
any, to the Redemption Date; PROVIDED, that if the Redemption Date is after a regular interest
payment record date and on or prior to the next Interest Payment Date, the accrued interest shall
be payable to the Holder of the redeemed Securities registered on the relevant record date, as
specified by the Company in the notice to the Trustee pursuant to Section 3.1.

3.5. DEPOSIT OF REDEMPTION PRICE.

     On or prior to the Redemption Date (but no later than 11:00 A.M. Eastern Time on such date),
the Company shall deposit with the Paying Agent money sufficient to pay the redemption price of and
accrued interest, if any, on all Securities to be redeemed on that date other than Securities or
portions thereof called for redemption on that date which have been delivered by the Company to the
Trustee for cancellation.

-18-

 

     On and after any Redemption Date, if money sufficient to pay the redemption price of, and
accrued interest on, Securities called for redemption shall have been made available in accordance
with the preceding paragraph and the Company and the Paying Agent are not prohibited from paying
such moneys to Holders, the Securities called for redemption will cease to accrue interest and the
only right of the Holders of such Securities will be to receive payment of the redemption price of
and, subject to the proviso in Section 3.4, accrued and unpaid interest on such Securities to the
Redemption Date. If any Security called for redemption shall not be so paid, interest will be
paid, from the Redemption Date until such redemption payment is made, on the unpaid principal of
the Security and any interest or premium, if any, not paid on such unpaid principal, in each case,
at the rate and in the manner provided in the Securities.

3.6. SECURITIES REDEEMED IN PART.

     Upon surrender of a Security of a Series that is redeemed in part, the Company shall execute,
and the Trustee shall authenticate, for a Holder a new Security of the same Series equal in
principal amount to the unredeemed portion of the Security surrendered.

ARTICLE 4

COVENANTS

4.1. PAYMENT OF SECURITIES.

     The Company shall pay the principal of, and interest and premium, if any, on, each Series of
Securities on the dates and in the manner provided in such Securities and this Indenture.

     An installment of principal or interest shall be considered paid on the date it is due if the
Trustee or Paying Agent holds on that date money designated for and sufficient to pay such
installment and is not prohibited from paying such money to the Holders pursuant to the terms of
this Indenture or otherwise.

     The Company shall pay interest on overdue principal, and overdue interest, to the extent
lawful, at the rate specified in the Series of Securities.

4.2. SEC REPORTS.

     The Company will deliver to the Trustee within 15 days after the filing of the same with the
SEC, copies of the quarterly and annual reports and of the information, documents and other
reports, if any, which the Company is required to file with the SEC pursuant to Section 13 or 15(d)
of the Exchange Act; PROVIDED, HOWEVER, that each such report or document will be deemed to be so
delivered to the Trustee if the Company files such report or document with the SEC through the
SEC’s EDGAR database no later than the time such report or document is required to be filed with
the SEC pursuant to the Exchange Act. Notwithstanding that the Company may not be subject to the
reporting requirements of Section 13 or 15(d) of the Exchange Act, the Company will file with the
SEC, to the extent permitted, and provide the Trustee with, such quarterly and annual reports and
such information, documents and other reports specified in Sections 13 and 15(d) of the Exchange
Act. The Company will also comply with the other provisions of TIA Section 314(a).

-19-

 

4.3. WAIVER OF STAY, EXTENSION OR USURY LAWS.

     The Company covenants (to the extent that it may lawfully do so) that it will not at any time
insist upon, or plead (as a defense or otherwise) or in any manner whatsoever claim or take the
benefit or advantage of, any stay, extension, usury or other law which would prohibit or forgive
the Company from paying all or any portion of the principal of, and/or interest and premium, if
any, on, the Securities as contemplated herein, wherever enacted, now or at any time hereafter in
force, or which may affect the covenants or the performance of this Indenture; and the Company
hereby expressly waives (to the extent that they may lawfully do so) all benefit or advantage of
any such law, and covenants that it will not hinder, delay or impede the execution of any power
herein granted to the Trustee, but will suffer and permit the execution of every such power as
though no such law had been enacted.

4.4. COMPLIANCE CERTIFICATE.

     (a) The Company shall deliver to the Trustee, within 120 days after the end of each fiscal
year of the Company, an Officers’ Certificate which complies with TIA Section 314(a)(4) stating
that a review of the activities of the Company and its Subsidiaries during such fiscal year has
been made under the supervision of the signing Officers with a view to determining whether the
Company has kept, observed, performed and fulfilled its obligations under this Indenture, and
further stating, as to each such Officer signing such certificate, that to the best of his or her
knowledge the Company has kept, observed, performed and fulfilled each and every covenant contained
in this Indenture and that there is no default in the performance or observance of any of the
terms, provisions and conditions hereof (or, if a Default or Event of Default shall have occurred,
describing all such Defaults or Events of Default of which he or she may have knowledge and what
action the Company is taking or proposes to take with respect thereto) and that to the best of his
or her knowledge no event has occurred and remains in existence by reason of which payments on
account of the principal of, or interest or premium, if any, on, the Securities is prohibited, or
if such event has occurred, a description of the event and what action the Company is taking or
proposes to take with respect thereto.

     (b) (i) If any Default or Event of Default has occurred and is continuing or (ii) if any
Holder seeks to exercise any remedy hereunder with respect to a claimed Default under this
Indenture or the Securities, within five Business Days after the Company becoming aware of such
occurrence the Company shall deliver to the Trustee an Officers’ Certificate specifying such event,
notice or other action and what action the Company is taking or proposes to take with respect
thereto.

4.5. CORPORATE EXISTENCE.

     Subject to Article 5, the Company shall do or cause to be done all things necessary to
preserve and keep in full force and effect its corporate existence, in accordance with the
organizational documents (as the same may be amended from time to time) of the Company and the
rights (charter and statutory), licenses and franchises of the Company; PROVIDED, HOWEVER, that the
Company shall not be required to preserve any such right, license or franchise, or its corporate
existence, if the Board of Directors shall determine that the

-20-

 

preservation thereof is no longer desirable in the conduct of the business of the Company and
that the loss thereof is not adverse in any material respect to the Holders.

ARTICLE 5

SUCCESSOR CORPORATION

5.1. LIMITATION ON CONSOLIDATION, MERGER AND SALE OF ASSETS.

     (a) The Company will not, in any transaction or series of transactions, merge or consolidate
with or into, or sell, assign, convey, transfer, lease or otherwise dispose of all or substantially
all of its properties and assets (as an entirety or substantially as an entirety in one transaction
or a series of related transactions), to any Person or Persons, unless at the time of and after
giving effect thereto (i) either (A) if the transaction or series of transactions is a merger or
consolidation, the Company shall be the surviving Person of such merger or consolidation, or (B)
the Person formed by such consolidation or into which the Company is merged or to which the
properties and assets of the Company are transferred (any such surviving Person or transferee
Person being the “Surviving Entity”) shall be a corporation organized and existing under the laws
of the United States of America, any state thereof or the District of Columbia, or a corporation or
comparable legal entity organized under the laws of a foreign jurisdiction and shall expressly
assume by a supplemental indenture executed and delivered to the Trustee, in form reasonably
satisfactory to the Trustee, all of the obligations of the Company (including, without limitation,
the obligation to pay the principal of, and premium and interest, if any, on, the Securities and
the performance of the other covenants) under the Securities of each Series and this Indenture, and
in each case, this Indenture shall remain in full force and effect; and (ii) immediately before and
immediately after giving effect to such transaction or series of transactions on a pro forma basis
(including, without limitation, any Indebtedness incurred or anticipated to be incurred in
connection with or in respect of such transaction or series of transactions), no Default or Event
of Default shall have occurred and be continuing.

     (b) In connection with any consolidation, merger or transfer of assets contemplated by this
Section 5.1, the Company shall deliver, or cause to be delivered, to the Trustee, in form and
substance reasonably satisfactory to the Trustee, an Officers’ Certificate and an Opinion of
Counsel, each stating that such consolidation, merger or transfer, and the supplemental indenture
in respect thereto, comply with this Section 5.1, and that all conditions precedent herein provided
for relating to such transaction or transactions have been complied with.

5.2. SUCCESSOR PERSON SUBSTITUTED.

     Upon any consolidation, merger or transfer of all or substantially all of the assets of the
Company in accordance with Section 5.1 above, the successor corporation formed by such
consolidation, or into which the Company is merged or to which such transfer is made, shall succeed
to, and be substituted for, and may exercise every right and power of, the Company under this
Indenture with the same effect as if such successor corporation had been named as the Company
herein, and thereafter (except with respect to any such transfer which is a lease) the predecessor
corporation shall be relieved of all obligations and covenants under this Indenture and the
Securities.

-21-

 

ARTICLE 6

DEFAULTS AND REMEDIES

6.1. EVENTS OF DEFAULT.

     “Events of Default,” wherever used herein with respect to Securities of any Series, means any
one of the following events, unless in the establishing Board Resolution, supplemental indenture or
Officers’ Certificate, it is provided that such Series shall not have the benefit of said Event of
Default:

          (1) there is a default in the payment of any principal of, or premium, if any, on, the
Securities when the same becomes due and payable at Maturity, upon acceleration, redemption or
otherwise;

          (2) there is a default in the payment of any interest on any Security of a Series when the
same becomes due and payable, and the Default continues for a period of 30 days;

          (3) the Company defaults in the observance or performance of any other covenant in the
Securities of a Series or in this Indenture for 60 days after written notice from the Trustee or
the Holders of not less than 25% in the aggregate principal amount of the Securities of such Series
then outstanding, which notice must specify the Default, demand that it be remedied and state that
the notice is a “Notice of Default”;

          (4) the Company or any Significant Subsidiary pursuant to or within the meaning of any
Bankruptcy Law:

     (A) commences a voluntary case,

     (B) consents to the entry of an order for relief against it in an involuntary
case,

     (C) consents to the appointment of a Custodian of it or for all or
substantially all of its property,

     (D) makes a general assignment for the benefit of its creditors, or

     (E) generally is not paying its debts as they become due;

          (5) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that:

     (A) is for relief against the Company or any Significant Subsidiary in an
involuntary case;

     (B) appoints a Custodian of the Company or any Significant Subsidiary, or for
all or substantially all of the property of the Company or any Significant
Subsidiary; or

-22-

 

     (C) orders the liquidation of the Company or any Significant Subsidiary, and
the order or decree remains unstayed and in effect for 90 consecutive days; or

          (6) any other Event of Default provided with respect to Securities of that Series, which is
specified in a Board Resolution, a supplemental indenture hereto or an Officers’ Certificate, in
accordance with Section 2.2(19).

     The term “Bankruptcy Law” means Title 11, U.S. Code, or any similar federal or state law for
the relief of debtors. The term “Custodian” means any receiver, trustee, assignee, liquidator or
similar official under any Bankruptcy Law.

     The Trustee may withhold notice of any Default (except in the payment of the principal of, or
interest or premium, if any, on, the Securities) to the Holders of the Securities of any Series in
accordance with Section 7.5. When a Default is cured, it ceases to exist.

6.2. ACCELERATION.

     If an Event of Default with respect to Securities of any Series at the time outstanding (other
than an Event of Default arising under Section 6.1(4) or (5)) occurs and is continuing, the Trustee
by written notice to the Company, or the Holders of not less than 25% in aggregate principal amount
of the Securities of that Series then outstanding by written notice to the Company and the Trustee,
may declare that the entire principal amount of all the Securities of that Series then outstanding
plus accrued and unpaid interest to the date of acceleration are immediately due and payable, in
which case such amounts shall become immediately due and payable; PROVIDED, HOWEVER, that after
such acceleration but before a judgment or decree based on such acceleration is obtained by the
Trustee, the Holders of a majority in aggregate principal amount of the outstanding Securities of
that Series may rescind and annul such acceleration and its consequences if (i) all existing Events
of Default, other than the nonpayment of accelerated principal, interest or premium, if any, that
has become due solely because of the acceleration, have been cured or waived, (ii) to the extent
the payment of such interest is lawful, interest on overdue installments of interest and overdue
principal, which has become due otherwise than by such declaration of acceleration, has been paid
and (iii) the rescission would not conflict with any judgment or decree. No such rescission shall
affect any subsequent Default or impair any right consequent thereto. In case an Event of Default
specified in Section 6.1(4) or (5) with respect to the Company occurs, such principal, premium, if
any, and interest amount with respect to all of the Securities of that Series shall be due and
payable immediately without any declaration or other act on the part of the Trustee or the Holders
of the Securities of that Series.

6.3. REMEDIES.

     If an Event of Default with respect to Securities of any Series at the time outstanding occurs
and is continuing, the Trustee may pursue any available remedy by proceeding at law or in equity to
collect the payment of the principal of, or interest and premium, if any, on, the Securities of
that Series, or to enforce the performance of any provision of the Securities of that Series or
this Indenture.

-23-

 

     The Trustee may maintain a proceeding even if it does not possess any of the Securities of
that Series or does not produce any of them in the proceeding. A delay or omission by the Trustee
or any Securityholder in exercising any right or remedy accruing upon an Event of Default shall not
impair the right or remedy or constitute a waiver of or acquiescence in the Event of Default. No
remedy is exclusive of any other remedy. All available remedies are cumulative to the extent
permitted by law.

6.4. WAIVER OF PAST DEFAULTS AND EVENTS OF DEFAULT.

     Subject to Sections 6.2, 6.7 and 8.2, the Holders of a majority in principal amount of the
Securities of any Series then outstanding have the right to waive any existing Default or Event of
Default with respect to such Series or compliance with any provision of this Indenture (with
respect to such Series) or the Securities of such Series. Upon any such waiver, such Default with
respect to such Series shall cease to exist, and any Event of Default with respect to such Series
arising therefrom shall be deemed to have been cured for every purpose of this Indenture; but no
such waiver shall extend to any subsequent or other Default or Event of Default or impair any right
consequent thereto. This Section 6.4 shall be in lieu of TIA Section 316(a)(1)(B), and TIA Section
316(a)(1)(B) is hereby expressly excluded from this Indenture and Section as permitted by the TIA.

6.5. CONTROL BY MAJORITY.

     Subject to Sections 6.2, 6.7 and 8.2, the Holders of a majority in principal amount of the
Securities of any Series then outstanding may direct the time, method and place of conducting any
proceeding for any remedy available to the Trustee or exercising any trust or power conferred on
the Trustee by this Indenture with respect to such Series. The Trustee, however, may refuse to
follow any direction that conflicts with law or this Indenture, or that the Trustee determines may
be unduly prejudicial to the rights of another Securityholder, or that may involve the Trustee in
personal liability; PROVIDED, that the Trustee may take any other action deemed proper by the
Trustee which is not inconsistent with such direction. This Section 6.5 shall be in lieu of TIA
Section 316(a)(1)(A), and TIA Section 316(a)(1)(A) is hereby expressly excluded from this Indenture
and Section as permitted by the TIA.

6.6. LIMITATION ON SUITS.

     Subject to Section 6.7, a Securityholder may not institute any proceeding or pursue any remedy
with respect to this Indenture or the Securities of a Series unless:

          (1) the Holder gives to the Trustee written notice of a continuing Event of Default with
respect to the Securities of that Series;

          (2) the Holders of at least 25% in aggregate principal amount of the Securities of such Series
then outstanding make a written request to the Trustee to pursue the remedy;

          (3) such Holder or Holders offer to the Trustee indemnity reasonably satisfactory to the
Trustee against any loss, liability or expense to be incurred in compliance with such request;

-24-

 

          (4) the Trustee does not comply with the request within 60 days after receipt of the request
and the offer of indemnity; and

          (5) no direction inconsistent with such written request has been given to the Trustee during
such 60-day period by the Holders of a majority in aggregate principal amount of the Securities of
such Series then outstanding.

     A Securityholder may not use this Indenture to prejudice the rights of another Securityholder,
or to obtain a preference or priority over another Securityholder.

6.7. RIGHTS OF HOLDERS TO RECEIVE PAYMENT.

     Notwithstanding any other provision of this Indenture, the right of any Holder of a Security
of a Series to receive payment of the principal of, and interest and premium, if any, on, the
Security of such Series on or after the respective due dates expressed in the Security of such
Series, or to bring suit for the enforcement of any such payment on or after such respective dates,
is absolute and unconditional, and shall not be impaired or affected without the consent of the
Holder.

6.8. COLLECTION SUIT BY TRUSTEE.

     If an Event of Default in payment of principal, interest or premium, if any, specified in
Section 6.1(1) or (2) with respect to Securities of any Series at the time outstanding occurs and
is continuing, the Trustee may recover judgment in its own name and as trustee of an express trust
against the Company (or any other obligor on the Securities of that Series) for the whole amount of
unpaid principal and premium, if any, and accrued interest remaining unpaid, together with interest
on overdue principal and premium, if any, and, to the extent that payment of such interest is
lawful, interest on overdue installments of interest, in each case at the rate then borne by the
Securities of that Series, and such further amounts as shall be sufficient to cover the costs and
expenses of collection, including the reasonable compensation, expenses, disbursements and advances
of the Trustee, its agents and counsel, as set forth in Section 7.7.

6.9. TRUSTEE MAY FILE PROOFS OF CLAIM.

     The Trustee may file such proofs of claim and other papers or documents, and take other
actions (including sitting on a committee of creditors), as may be necessary or advisable in order
to have the claims of the Trustee (including any claim for the reasonable compensation, expenses,
disbursements and advances of the Trustee, its agents and counsel) and the Securityholders allowed
in any judicial proceedings relative to the Company (or any other obligor on the Securities), any
of their respective creditors or any of their respective property, and the Trustee shall be
entitled and empowered to collect and receive any monies or other property payable or deliverable
on any such claims, and to distribute the same after deduction of its charges and expenses to the
extent that any such charges and expenses are not paid out of the estate in any such proceedings,
and any custodian in any such judicial proceeding is hereby authorized by each Securityholder to
make such payments to the Trustee, and in the event that the Trustee shall consent to the making of
such payments directly to the Securityholders, to pay to the Trustee any amount due to it for the
reasonable compensation, expenses, disbursements

-25-

 

and advances of the Trustee, its agents and counsel, and any other amounts due the Trustee
under Section 7.7.

     Nothing herein contained shall be deemed to authorize the Trustee to authorize or consent to,
or accept or adopt on behalf of any Securityholder, any plan of reorganization, arrangement,
adjustment or composition affecting the Securities of a Series or the rights of any Holder thereof,
or to authorize the Trustee to vote in respect of the claim of any Securityholder in any such
proceedings.

6.10. PRIORITIES.

     If the Trustee collects any money pursuant to this Article 6, it shall pay out the money in
the following order:

FIRST: to the Trustee for amounts due under Section 7.7;

SECOND: to Securityholders for amounts then due and unpaid for the
principal of, and interest and premium, if any, on, the Securities
in respect of which, or for the benefit of which, such money has
been collected, ratably, without preference or priority of any kind,
according to the amounts due and payable on such Securities; for
principal and any premium and interest, respectively; and

THIRD: to the Company.

     The Trustee may fix a record date and payment date for any payment to Securityholders pursuant
to this Section 6.10. At least 15 days before such record date, the Trustee shall mail to each
Securityholder a notice that states the record date, the payment date and amount to be paid.

6.11. UNDERTAKING FOR COSTS.

     In any suit for the enforcement of any right or remedy under this Indenture, or in any suit
against the Trustee for any action taken or omitted by it as Trustee, a court in its discretion may
require the filing by any party litigant in the suit of an undertaking to pay the costs of the
suit, and the court in its discretion may assess reasonable costs, including reasonable attorneys’
fees, against any party litigant in the suit, having due regard to the merits and good faith of the
claims or defenses made by the party litigant. This Section 6.11 does not apply to a suit by the
Trustee, a suit by a Holder pursuant to Section 6.7 or a suit by Holders of more than 10% in
principal amount of the Securities of a Series then outstanding.

-26-

 

ARTICLE 7

TRUSTEE

7.1. DUTIES OF TRUSTEE.

     (a) If an Event of Default has occurred and is continuing, the Trustee shall exercise such of
the rights and powers vested in it by this Indenture and use the same degree of care and skill in
their exercise as a prudent Person would exercise or use under the same circumstances in the
conduct of his own affairs.

     (b) Except during the continuance of an Event of Default:

          (1) The Trustee need perform only those duties that are specifically set forth in this
Indenture, and no covenants or obligations shall be implied in this Indenture against the Trustee.

          (2) In the absence of bad faith on its part, the Trustee may conclusively rely, as to the
truth of the statements and the correctness of the opinions expressed therein, upon certificates or
opinions furnished to the Trustee and conforming to the requirements of this Indenture, but, in the
case of any such certificates or opinions which by any provision hereof are specifically required
to be furnished to the Trustee, the Trustee shall be under a duty to examine the same to determine
whether or not they conform to the requirements of this Indenture.

     (c) The Trustee may not be relieved from liability for its own negligent action, its own
negligent failure to act or its own willful misconduct, except that:

          (1) This paragraph does not limit the effect of paragraph (b) of this Section 7.1.

          (2) The Trustee shall not be liable for any error of judgment made in good faith by a
Responsible Officer, unless it is proved that the Trustee was negligent in ascertaining the
pertinent facts.

          (3) The Trustee shall not be liable with respect to any action it takes or omits to take in
good faith in accordance with a direction received by it pursuant to Sections 6.2 and 6.5.

     (d) No provision of this Indenture shall require the Trustee to expend or risk its own funds,
or otherwise incur any financial liability, in the performance of any of its rights or powers if it
shall have reasonable grounds for believing that repayment of such funds or adequate indemnity
satisfactory to it against such risk or liability is not reasonably assured to it.

     (e) Whether or not therein expressly so provided, paragraphs (a), (b), (c) and (d) of this
Section 7.1 shall govern every provision of this Indenture that in any way relates to the Trustee.

-27-

 

     (f) The Trustee and Paying Agent shall not be liable for interest on any money received by
either of them, except as the Trustee and Paying Agent may agree in writing with the Company.
Money held in trust by the Trustee need not be segregated from other funds except to the extent
required by the law.

     (g) The Paying Agent, the Registrar and any authenticating agent shall be entitled to the
protections, immunities and standard of care set forth in paragraphs (a), (b), (c), (d) and (f) of
this Section 7.1 and in Section 7.2 with respect to the Trustee.

7.2. RIGHTS OF TRUSTEE.

     (a) Subject to Section 7.1:

          (1) The Trustee may rely on, and shall be protected in acting or refraining from acting upon,
any document reasonably believed by it to be genuine and to have been signed or presented by the
proper Person. The Trustee need not investigate any fact or matter stated in the document.

          (2) Before the Trustee acts or refrains from acting, it may require an Officers’ Certificate
or an Opinion of Counsel, or both, which shall conform to the provisions of Section 10.5. The
Trustee shall be protected and shall not be liable for any action it takes or omits to take in good
faith in reliance on such certificate or opinion.

          (3) The Trustee may act through agents and attorneys, and shall not be responsible for the
misconduct or negligence of any agent appointed by it with due care.

          (4) The Trustee shall not be liable for any action it takes or omits to take in good faith
which it reasonably believes to be authorized or within its rights or powers.

          (5) The Trustee may consult with counsel reasonably acceptable to the Trustee, which may be
counsel to the Company, and the advice or opinion of such counsel as to matters of law shall be
full and complete authorization and protection from liability in respect of any action taken,
omitted or suffered by it hereunder in good faith and in accordance with the advice or opinion of
such counsel.

          (6) The Trustee shall be under no obligation to exercise any of the rights or powers vested in
it by this Indenture at the request, order or direction of any of the Holders pursuant to the
provisions of this Indenture, unless such Holders shall have offered to the Trustee reasonable
security or indemnity against the costs, expenses and liabilities which may be incurred therein or
thereby.

          (7) The Trustee shall not be deemed to have knowledge of any fact or matter (including,
without limitation, a Default or Event of Default) unless such fact or matter is known to a
Responsible Officer of the Trustee.

          (8) Unless otherwise expressly provided herein or in the Securities of a Series or the related
Board Resolution, supplemental indenture or Officers’ Certificate, the Trustee shall not have any
responsibility with respect to reports, notices, certificates or other documents

-28-

 

filed with it hereunder, except to make them available for inspection, at reasonable times, by
Securityholders, it being understood that delivery of such reports, information and documents to
the Trustee is for informational purposes only and the Trustee’s receipt of such shall not
constitute constructive notice of any information contained therein or determinable from
information contained therein, including the Company’s compliance with any of its covenants
hereunder (except as set forth in Section 4.4).

7.3. INDIVIDUAL RIGHTS OF TRUSTEE.

     The Trustee in its individual or any other capacity may become the owner or pledgee of
Securities, and may make loans to, accept deposits from, perform services for or otherwise deal
with the Company, or any Affiliate thereof, with the same rights it would have if it were not
Trustee. Any Agent may do the same with like rights. The Trustee, however, shall be subject to
Sections 7.10 and 7.11.

7.4. TRUSTEE’S DISCLAIMER.

     The Trustee makes no representation as to the validity or adequacy of this Indenture or the
Securities (except that the Trustee represents that it is duly authorized to execute and deliver
this Indenture and authenticate the Securities and perform its obligations hereunder), and the
Trustee shall not be accountable for the Company’s use of the proceeds from the sale of Securities
or any money paid to the Company pursuant to the terms of this Indenture, and the Trustee shall not
be responsible for any statement in the Securities other than its certificates of authentication.

7.5. NOTICE OF DEFAULT.

     If a Default or an Event of Default occurs and is continuing with respect to the Securities of
any Series, and if it is known to the Trustee, the Trustee shall mail to each Securityholder of the
Securities of that Series notice of the Default or the Event of Default, as the case may be, within
90 days after it occurs or, if later, after a Responsible Officer of the Trustee has knowledge of
such Default or Event of Default (except if such Default or Event of Default has been validly cured
or waived before the giving of such notice). Except in the case of a Default or an Event of
Default in payment of the principal of, or interest or premium, if any, on, any Security of any
Series, the Trustee may withhold the notice if and so long as the Board of Directors of the
Trustee, the executive committee or any trust committee of such board and/or its Responsible
Officers in good faith determine(s) that withholding the notice is in the interests of the
Securityholders of that Series.

7.6. REPORTS BY TRUSTEE TO HOLDERS.

     If and to the extent required by the TIA, within 60 days after April 1 of each year,
commencing the April 1 following the date of this Indenture, the Trustee shall mail to each
Securityholder a brief report dated as of such April 1 that complies with TIA Section 313(a). The
Trustee also shall comply with TIA Sections 313(b) and 313(c).

     A copy of each report at the time of its mailing to Securityholders shall be filed with the
SEC and any stock exchange on which the Securities of that Series are listed. The Company

-29-

 

shall promptly notify the Trustee when the Securities of any Series are listed on any stock
exchange or any delisting thereof, and the Trustee shall comply with TIA Section 313(d).

7.7. COMPENSATION AND INDEMNITY.

     The Company shall pay to the Trustee from time to time reasonable compensation for its
services. The Trustee’s compensation shall not be limited by any provision of law on compensation
of a trustee of an express trust. The Company shall reimburse the Trustee within 45 days after
receipt of request for all reasonable out-of-pocket disbursements and expenses incurred or made by
it in connection with its duties under this Indenture, including the reasonable compensation,
disbursements and expenses of the Trustee’s agents and counsel.

     The Company shall indemnify the Trustee for, and hold it harmless against, any and all loss or
liability incurred by it in connection with the acceptance or performance of its duties under this
Indenture including the reasonable costs and expenses of defending itself against any claim or
liability in connection with the exercise or performance of any of its powers or duties hereunder.
The Trustee shall notify the Company promptly of any claim asserted against the Trustee for which
it may seek indemnity.

     The failure by the Trustee to so notify the Company shall not however relieve the Company of
its obligations. Notwithstanding the foregoing, the Company need not reimburse the Trustee for any
expense or indemnify it against any loss or liability incurred by the Trustee through its
negligence or bad faith. To secure the payment obligations of the Company in this Section 7.7, the
Trustee shall have a lien prior to the Securities of any Series on all money or property held or
collected by the Trustee except such money or property held in trust to pay the principal of,
interest and premium, if any, on particular Securities of that Series.

     When the Trustee incurs expenses or renders services after an Event of Default specified in
Section 6.1(4) or (5) occurs, the expenses and the compensation for the services are intended to
constitute expenses of administration under any Bankruptcy Law.

     For purposes of this Section 7.7, the term “Trustee” shall include any trustee appointed
pursuant to this Article 7.

7.8. REPLACEMENT OF TRUSTEE.

     The Trustee may resign with respect to the Securities of one or more Series by so notifying
the Company in writing at least 90 days in advance of such resignation.

     The Holders of a majority in principal amount of the outstanding Securities of any Series may
remove the Trustee with respect to that Series by notifying the removed Trustee in writing and may
appoint a successor Trustee with respect to that Series with the consent of the Company, which
consent shall not be unreasonably withheld. The Company may remove the Trustee with respect to
that Series at its election if:

          (1) the Trustee fails to comply with, or ceases to be eligible under, Section 7.10;

-30-

 

          (2) the Trustee is adjudged a bankrupt or an insolvent, or an order for relief is entered with
respect to the Trustee, under any Bankruptcy Law;

          (3) a Custodian or other public officer takes charge of the Trustee or its property; or

          (4) the Trustee otherwise becomes incapable of acting.

          (5) If the Trustee resigns or is removed, or if a vacancy exists in the office of Trustee,
with respect to any Series of Securities for any reason, the Company shall promptly appoint, by
Board Resolution, a successor Trustee.

     If a successor Trustee with respect to the Securities of one or more Series does not take
office within 60 days after the retiring Trustee resigns or is removed, the retiring Trustee, the
Company or the Holders of at least 10% in principal amount of the outstanding Securities of the
applicable Series may petition any court of competent jurisdiction for the appointment of a
successor Trustee.

     If the Trustee with respect to the Securities of one or more Series fails to comply with
Section 7.10, any Securityholder of the applicable Series may petition any court of competent
jurisdiction for the removal of the Trustee and the appointment of a successor Trustee.

     A successor Trustee shall deliver a written acceptance of its appointment to the retiring
Trustee and to the Company. Immediately following such delivery, (i) the retiring Trustee with
respect to one or more Series shall, subject to its rights under Section 7.7, transfer all property
held by it as Trustee with respect to such Series to the successor Trustee, (ii) the resignation or
removal of the retiring Trustee shall become effective and (iii) the successor Trustee with respect
to such Series shall have all the rights, powers and duties of the Trustee under this Indenture. A
successor Trustee with respect to the Securities of one or more Series shall mail notice of its
succession to each Securityholder of such Series.

7.9. SUCCESSOR TRUSTEE BY CONSOLIDATION, MERGER OR CONVERSION.

     If the Trustee, or any Agent, consolidates with, merges or converts into, or transfers all or
substantially all of its corporate trust assets to, another corporation, subject to Section 7.10,
the successor corporation without any further act shall be the successor Trustee or Agent, as the
case may be.

7.10. ELIGIBILITY; DISQUALIFICATION.

     This Indenture shall always have a Trustee who satisfies the requirements of TIA Sections
310(a)(1), (2) and (5) in every respect. The Trustee (or in the case of a Trustee that is a Person
included in a bank holding company system, the related bank holding company) shall have a combined
capital and surplus of at least $100,000,000 as set forth in its most recent published annual
report of condition. The Trustee shall comply with TIA Section 310(b), including the provision in
Section 310(b)(1). In addition, if the Trustee is a Person included in a bank holding company
system, the Trustee, independently of such bank holding company, shall meet the capital
requirements of TIA Section 310(a)(2). If at any time the Trustee shall cease to

-31-

 

be eligible in accordance with the provisions of this Section 7.10, it shall resign
immediately in the manner and with the effect specified in this Article 7.

7.11. PREFERENTIAL COLLECTION OF CLAIMS AGAINST COMPANY.

     The Trustee shall comply with TIA Section 311(a), excluding any creditor relationship listed
in TIA Section 311(b). A Trustee who has resigned or been removed shall be subject to TIA Section
311(a) to the extent indicated therein.

7.12. PAYING AGENTS.

     The Company shall cause each Paying Agent other than the Trustee to execute and deliver to it
and the Trustee an instrument in which such agent shall agree with the Trustee, subject to the
provisions of this Section 7.12:

          (1) that it will hold all sums held by it as agent for the payment of the principal of, or
interest or premium, if any, on, the Securities (whether such sums have been paid to it by the
Company or by any obligor on the Securities) in trust for the benefit of Holders of the Securities
or the Trustee;

          (2) that it will at any time during the continuance of any Event of Default, upon written
request from the Trustee, deliver to the Trustee all sums so held in trust by it together with a
full accounting thereof; and

          (3) that it will give the Trustee written notice within three Business Days after any failure
of the Company (or by any obligor on the Securities) in the payment of any installment of the
principal of, or interest or premium, if any, on, the Securities when the same shall be due and
payable.

ARTICLE 8

AMENDMENTS, SUPPLEMENTS AND WAIVERS

8.1. WITHOUT CONSENT OF HOLDERS.

     The Company, when authorized by a Board Resolution, and the Trustee may amend or supplement
this Indenture or the Securities of one or more Series without notice to or consent of any
Securityholder:

          (1) to comply with Section 5.1;

          (2) to provide for certificated Securities in addition to uncertificated Securities;

          (3) to comply with any requirements of the SEC under the TIA;

-32-

 

          (4) to cure any ambiguity, defect or inconsistency, or to make any other change herein or in
the Securities that does not materially and adversely affect the rights of any Securityholder;

          (5) to provide for the issuance of, and establish the form and terms and conditions of,
Securities of any Series as permitted by this Indenture; or

          (6) to evidence and provide for the acceptance of appointment hereunder by a successor Trustee
with respect to the Securities of one or more Series, and to add to or change any of the provisions
of this Indenture as shall be necessary to provide for or facilitate the administration of the
trusts hereunder by more than one Trustee.

     The Trustee is hereby authorized to join with the Company in the execution of any supplemental
indenture authorized or permitted by the terms of this Indenture, and to make any further
appropriate agreements and stipulations which may be therein contained, but the Trustee shall not
be obligated to enter into any such supplemental indenture which adversely affects its own rights,
duties or immunities under this Indenture.

8.2. WITH CONSENT OF HOLDERS.

     (a) The Company, when authorized by a Board Resolution, and the Trustee may amend or
supplement this Indenture or the Securities of one or more Series with the written consent of the
Holders of not less than a majority in aggregate principal amount of the outstanding Securities of
such Series affected by such amendment or supplement without notice to any Securityholder. The
Holders of not less than a majority in aggregate principal amount of the outstanding Securities of
each such Series affected by such amendment or supplement may waive compliance by the Company in a
particular instance with any provision of this Indenture or the Securities of such Series without
notice to any Securityholder. Subject to Section 8.4, without the consent of each Securityholder
affected, however, an amendment, supplement or waiver may not:

          (1) reduce the amount of Securities whose Holders must consent to an amendment, supplement or
waiver to this Indenture or the Securities;

          (2) reduce the rate of, or change the time for payment of, interest on any Security;

          (3) reduce the principal, or change the Stated Maturity, of any Security, or reduce the amount
of, or postpone the date fixed for, the payment of any sinking fund or analogous obligation;

          (4) make any Security payable in money other than that stated in the Security;

          (5) change the amount or time of any payment required by the Securities, or reduce the premium
payable upon any redemption of the Securities, or change the time before which no such redemption
may be made;

-33-

 

          (6) waive a Default or Event of Default in the payment of the principal of, or interest or
premium, if any, on, any Security (except a rescission of acceleration of the Securities of any
Series by the Holders of at least a majority in principal amount of the outstanding Securities of
such Series and a waiver of the payment default that resulted from such acceleration);

          (7) waive a redemption payment with respect to any Security, or change any of the provisions
with respect to the redemption of any Securities;

          (8) make any changes in Section 6.6 or this Section 8.2, except to increase any percentage of
Securities the Holders of which must consent to any matter; or

          (9) take any other action otherwise prohibited by this Indenture to be taken without the
consent of each Holder affected thereby.

     (b) Upon the request of the Company, accompanied by a Board Resolution authorizing the
execution of any such supplemental indenture, and upon the receipt by the Trustee of evidence
reasonably satisfactory to the Trustee of the consent of the Securityholders as aforesaid and of
the documents described in Section 8.6, the Trustee shall join with the Company in the execution of
such supplemental indenture, unless such supplemental indenture affects the Trustee’s own rights,
duties or immunities under this Indenture, in which case the Trustee may in its discretion, but
shall not be obligated to, enter into such supplemental indenture.

     (c) It shall not be necessary for the consent of the Holders under this section to approve the
particular form of any proposed amendment, supplement or waiver, but it shall be sufficient if such
consent approves the substance thereof.

     After an amendment or supplement under this Section becomes effective, the Company shall mail
to Securityholders a notice briefly describing the amendment or supplement. Any failure of the
Company to mail any such notice, or any defect therein, shall not, however, in any way impair or
affect the validity of any supplemental indenture.

8.3. COMPLIANCE WITH TRUST INDENTURE ACT.

     Every amendment to, or supplement of, this Indenture or the Securities shall comply with the
TIA as then in effect.

8.4. REVOCATION AND EFFECT OF CONSENTS.

     Until an amendment, supplement, waiver or other action becomes effective, a consent to it by a
Holder of a Security is a continuing consent conclusive and binding upon such Holder and every
subsequent Holder of the same Security or portion thereof, and of any Security issued upon the
transfer thereof or in exchange therefor or in place thereof, even if notation of the consent is
not made on any such Security. Any such Holder or subsequent Holder, however, may revoke the
consent as to his Security or portion of a Security, if the Trustee receives the notice of
revocation before the date the amendment, supplement, waiver or other action becomes effective.

-34-

 

     The Company may, but shall not be obligated to, fix a record date for the purpose of
determining the Holders entitled to consent to any amendment, supplement or waiver, which record
date shall be at least 30 days prior to the first solicitation of such consent. If a record date
is fixed, then, notwithstanding the preceding paragraph, those Persons who were Holders at such
record date (or their duly designated proxies), and only such Persons, shall be entitled to consent
to such amendment, supplement or waiver, or to revoke any consent previously given, whether or not
such Persons continue to be Holders after such record date.

     After an amendment, supplement, waiver or other action becomes effective, it shall bind every
Securityholder, unless it makes a change described in any of clauses (1) through (9) of Section
8.2. In that case, the amendment, supplement, waiver or other action shall bind each Holder of a
Security who has consented to it and every subsequent Holder of a Security or portion of a Security
that evidences the same debt as the consenting Holder’s Security; PROVIDED, that any such waiver
shall not impair or affect the right of any Holder to receive payment of the principal of, and
interest and premium, if any, on, a Security, on or after the respective due dates expressed in
such Security, or to bring suit for the enforcement of any such payment on or after such respective
dates without the consent of such Holder.

8.5. NOTATION ON OR EXCHANGE OF SECURITIES.

     If an amendment, supplement or waiver changes the terms of a Security of any Series, the
Trustee may request the Holder of such Security to deliver it to the Trustee. In such case, the
Trustee shall place an appropriate notation on such Security about the changed terms and return it
to the Holder. Alternatively, the Company, in exchange for such Security, may issue, and the
Trustee shall authenticate, a new security that reflects the changed terms. Failure to make the
appropriate notation or issue a new Security shall not affect the validity and effect of such
amendment, supplement or waiver.

8.6. TRUSTEE TO SIGN AMENDMENTS, ETC.

     The Trustee shall sign any amendment, supplement or waiver authorized pursuant to this Article
8 if the amendment, supplement or waiver does not adversely affect the rights, duties, liabilities
or immunities of the Trustee. If it does, the Trustee may, but need not, sign it. In signing or
refusing to sign such amendment, supplement or waiver the Trustee shall be entitled to receive and,
subject to Section 7.1, shall be fully protected in relying upon an Officers’ Certificate and an
Opinion of Counsel stating that such amendment, supplement or waiver is authorized or permitted by
this Indenture. The Company may not sign an amendment or supplement until the Board of Directors
of the Company approves it.

ARTICLE 9

DISCHARGE OF INDENTURE; DEFEASANCE

9.1. DISCHARGE OF INDENTURE.

     The Company may terminate its obligations under the Securities of any Series and this
Indenture with respect to such Series, except the obligations referred to in the last paragraph of
this Section 9.1, if there shall have been canceled by the Trustee, or delivered to the Trustee for

-35-

 

cancellation, all Securities of such Series theretofore authenticated and delivered (other
than any Securities of such Series that are asserted to have been destroyed, lost or stolen and
that shall have been replaced as provided in Section 2.8) and the Company has paid all sums payable
by it hereunder or deposited all required sums with the Trustee.

     After such delivery the Trustee upon request shall acknowledge in a writing prepared by or on
behalf of the Company the discharge of the Company’s obligations under the Securities of such
Series and this Indenture, except for those surviving obligations specified below.

     Notwithstanding the satisfaction and discharge of this Indenture, the obligations of the
Company in Sections 7.7, 9.5 and 9.6 shall survive.

9.2. LEGAL DEFEASANCE.

     The Company may at its option, by Board Resolution, be discharged from its obligations with
respect to the Securities of any Series on the date upon which the conditions set forth in Section
9.4 below are satisfied (hereinafter, “Legal Defeasance”). For this purpose, such Legal Defeasance
means that the Company shall be deemed to have paid and discharged the entire indebtedness
represented by the Securities of such Series and to have satisfied all its other obligations under
such Securities and this Indenture insofar as such Securities are concerned (and the Trustee, at
the expense of the Company, shall, subject to Section 9.6, execute proper instruments acknowledging
the same, as are delivered to it by the Company), except for the following, which shall survive
until otherwise terminated or discharged hereunder: (A) the rights of Holders of outstanding
Securities of such Series to receive solely from the trust funds described in Section 9.4 and as
more fully set forth in such section, payments in respect of the principal of, and interest and
premium, if any, on, the Securities of such Series when such payments are due, (B) the Company’s
obligations with respect to the Securities of such Series under Sections 2.4, 2.5, 2.6, 2.7, 2.8
and 2.9, (C) the rights, powers, trusts, duties and immunities of the Trustee hereunder (including
claims of, or payments to, the Trustee under or pursuant to Section 7.7) and (D) this Article 9.
Subject to compliance with this Article 9, the Company may exercise its option under this Section
9.2 with respect to the Securities of any Series notwithstanding the prior exercise of its option
under Section 9.3 below with respect to the Securities of such Series.

9.3. COVENANT DEFEASANCE.

     At the option of the Company, pursuant to a Board Resolution, the Company shall be released
from its obligations with respect to the outstanding Securities of any Series under Sections 4.2
through 4.5, inclusive, and Section 5.1, with respect to the outstanding Securities of such Series,
on and after the date the conditions set forth in Section 9.4 are satisfied (hereinafter, “Covenant
Defeasance”). For this purpose, such Covenant Defeasance means that the Company may omit to comply
with and shall have no liability in respect of any term, condition or limitation set forth in any
such specified section or portion thereof, whether directly or indirectly by reason of any
reference elsewhere herein to any such specified Section or portion thereof or by reason of any
reference in any such specified section or portion thereof to any other provision herein or in any
other document, but the remainder of this Indenture and the Securities of any Series shall be
unaffected thereby.

-36-

 

9.4. CONDITIONS TO LEGAL DEFEASANCE OR COVENANT DEFEASANCE.

     The following shall be the conditions to application of Section 9.2 or Section 9.3 to the
outstanding Securities of a Series:

          (1) the Company shall irrevocably have deposited or caused to be deposited with the Trustee
(or another trustee satisfying the requirements of Section 7.10 who shall agree to comply with the
provisions of this Article 9 applicable to it) as funds in trust for the purpose of making the
following payments, specifically pledged as security for, and dedicated solely to, the benefit of
the Holders of the Securities, (A) money in an amount, or (B) U.S. Government Obligations or
Foreign Government Obligations which through the scheduled payment of principal and interest in
respect thereof in accordance with their terms will provide, not later than the due date of any
payment, money in an amount, or (C) a combination thereof, sufficient, in the opinion of a
nationally recognized firm of independent public accountants expressed in a written certification
thereof delivered to the Trustee, to pay and discharge, and which shall be applied by the Trustee
(or other qualifying trustee) to pay and discharge, the principal of, and accrued interest and
premium, if any, on, the outstanding Securities of such Series at the Stated Maturity of such
principal, interest or premium, if any, or on dates for payment and redemption of such principal,
interest and premium, if any, selected in accordance with the terms of this Indenture and of the
Securities of such Series;

          (2) no Event of Default or Default with respect to the Securities of such Series shall have
occurred and be continuing on the date of such deposit, or shall have occurred and be continuing at
any time during the period ending on the 91st day after the date of such deposit or, if longer,
ending on the day following the expiration of the longest preference period under any Bankruptcy
Law applicable to the Company in respect of such deposit as specified in the Opinion of Counsel
identified in paragraph (8) below (it being understood that this condition shall not be deemed
satisfied until the expiration of such period);

          (3) such Legal Defeasance or Covenant Defeasance shall not cause the Trustee to have a
conflicting interest for purposes of the TIA with respect to any securities of the Company;

          (4) such Legal Defeasance or Covenant Defeasance shall not result in a breach or violation of,
or constitute default under, any other agreement or instrument to which the Company is a party or
by which it is bound;

          (5) the Company shall have delivered to the Trustee an Opinion of Counsel stating that, as a
result of such Legal Defeasance or Covenant Defeasance, neither the trust nor the Trustee will be
required to register as an investment company under the Investment Company Act of 1940, as amended;

          (6) in the case of an election under Section 9.2, the Company shall have delivered to the
Trustee an Opinion of Counsel stating that (i) the Company has received from, or there has been
published by, the Internal Revenue Service a ruling to the effect that or (ii) there has been a
change in any applicable Federal income tax law with the effect that, and such opinion shall
confirm that, the Holders of the outstanding Securities of such Series or Persons in

-37-

 

their positions will not recognize income, gain or loss for Federal income tax purposes solely
as a result of such Legal Defeasance and will be subject to Federal income tax on the same amounts,
in the same manner, including as a result of prepayment, and at the same times as would have been
the case if such Legal Defeasance had not occurred;

     (7) in the case of an election under Section 9.3, the Company shall have delivered to the
Trustee an Opinion of Counsel to the effect that the Holders of the outstanding Securities of such
Series will not recognize income, gain or loss for Federal income tax purposes as a result of such
Covenant Defeasance, and will be subject to Federal income tax on the same amounts, in the same
manner and at the same times as would have been the case if such Covenant Defeasance had not
occurred;

     (8) the Company shall have delivered to the Trustee an Officers’ Certificate and an Opinion of
Counsel, each stating that all conditions precedent provided for in this Article 9 relating to
either the Legal Defeasance under Section 9.2 or the Covenant Defeasance under Section 9.3 (as the
case may be) have been complied with;

     (9) the Company shall have delivered to the Trustee an Officers’ Certificate stating that the
deposit under clause (1) was not made by the Company with the intent of defeating, hindering,
delaying or defrauding any creditors of the Company or others; and

     (10) the Company shall have paid, or duly provided for payment under terms mutually
satisfactory to the Company and the Trustee, all amounts then due to the Trustee pursuant to
Section 7.7.

	9.5.	 	DEPOSITED MONEY AND U.S. AND FOREIGN GOVERNMENT OBLIGATIONS TO BE HELD IN TRUST; OTHER
MISCELLANEOUS PROVISIONS.

     All money, U.S. Government Obligations and Foreign Government Obligations (including the
proceeds thereof) deposited with the Trustee pursuant to Section 9.4 in respect of the outstanding
Securities shall be held in trust and applied by the Trustee, in accordance with the provisions of
such Securities and this Indenture, to the payment, either directly or through any Paying Agent as
the Trustee may determine, to the Holders of such Securities, of all sums due and to become due
thereon in respect of principal, accrued interest and premium, if any, but such money need not be
segregated from other funds except to the extent required by law.

     The Company shall pay and indemnify the Trustee against any tax, fee or other charge imposed
on or assessed against the U.S. Government Obligations and Foreign Government Obligations deposited
pursuant to Section 9.4 or the principal, interest and premium, if any, received in respect thereof
other than any such tax, fee or other charge which by law is for the account of the Holders of the
outstanding Securities.

     Anything in this Article 9 to the contrary notwithstanding, but subject to payment of any of
its outstanding fees and expenses, the Trustee shall deliver or pay to the Company from time to
time upon Company Request any money, U.S. Government Obligations or Foreign Government Obligations
held by the Trustee as provided in Section 9.4 which, in the opinion of a nationally-recognized
firm of independent public accountants expressed in a written certification thereof delivered to
the Trustee, are in excess of the amount thereof which would

-38-

 

then be required to be deposited to effect an equivalent Legal Defeasance or Covenant
Defeasance.

9.6. REINSTATEMENT.

     If the Trustee or Paying Agent is unable to apply any money, U.S. Government Obligations or
Foreign Government Obligations in accordance with Section 9.1, 9.2, 9.3 or 9.4 by reason of any
legal proceeding or by reason of any order or judgment of any court or governmental authority
enjoining, restraining or otherwise prohibiting such application, the Company’s obligations under
this Indenture and the Securities shall be revived and reinstated as though no deposit had occurred
pursuant to this Article 9 until such time as the Trustee or Paying Agent is permitted to apply all
such money, U.S. Government Obligations or Foreign Government Obligations, as the case may be, in
accordance with Section 9.1, 9.2, 9.3 or 9.4; PROVIDED, HOWEVER, that if the Company has made any
payment of principal of, or accrued interest or premium, if any, on, any Securities because of the
reinstatement of its obligations, the Company shall be subrogated to the rights of the Holders of
such Securities to receive such payment from the money, U.S. Government Obligations or Foreign
Government Obligations held by the Trustee or Paying Agent.

9.7. MONEYS HELD BY PAYING AGENT.

     In connection with the satisfaction and discharge of this Indenture, all moneys then held by
any Paying Agent under the provisions of this Indenture shall, upon demand of the Company, be paid
to the Trustee, or, if sufficient moneys have been deposited pursuant to Section 9.1, to the
Company, and thereupon such Paying Agent shall be released from all further liability with respect
to such moneys.

9.8. MONEYS HELD BY TRUSTEE.

     Any moneys deposited with the Trustee or any Paying Agent or then held by the Company in trust
for the payment of the principal of, or interest or premium, if any, on, any Security that are not
applied but remain unclaimed by the Holder of such Security for two years after the date upon which
the principal of, or interest or premium, if any, on, such Security shall have respectively become
due and payable shall be repaid to the Company upon Company Request, or if such moneys are then
held by the Company in trust, such moneys shall be released from such trust; and the Holder of such
Security entitled to receive such payment shall thereafter, as an unsecured general creditor, look
only to the Company for the payment thereof, and all liability of the Trustee or such Paying Agent
with respect to such trust money shall thereupon cease; PROVIDED, HOWEVER, that the Trustee or any
such Paying Agent, before being required to make any such repayment, may, at the expense of the
Company, either mail to each Securityholder affected, at the address shown in the register of the
Securities maintained by the Registrar, or cause to be published once a week for two successive
weeks, in a newspaper published in the English language, customarily published each Business Day
and of general circulation in the City of New York, New York, a notice that such money remains
unclaimed and that, after a date specified therein, which shall not be less than 30 days from the
date of such mailing or publication, any unclaimed balance of such moneys then remaining will be
repaid to the Company. After payment to the Company or the release of any money held in trust by
the

-39-

 

Company, Securityholders entitled to the money must look only to the Company for payment as
general creditors, unless applicable abandoned property law designates another Person.

ARTICLE 10

MISCELLANEOUS

10.1. TRUST INDENTURE ACT CONTROLS.

     If any provision of this Indenture limits, qualifies or conflicts with another provision which
is required to be included in this Indenture by the TIA, the required provision shall control. If
any provision of this Indenture modifies or excludes any provision of the TIA which may be so
modified or excluded, the latter provision shall be deemed to apply to this Indenture as so
modified or to be excluded, as the case may be.

10.2. NOTICES.

     Any notice or communication shall be given in writing and delivered in Person, sent by
facsimile (and receipt confirmed by telephone or electronic transmission report), delivered by
commercial courier service or mailed by first-class mail, postage prepaid, addressed as follows:

          If to the Company:

RXi Pharmaceuticals Corporation

60 Prescott Street

Worcester, MA 01605

Fax: (508) 767-3861

Attention: General Counsel

          Copy to:

Ropes & Gray LLP

One International Place

Boston, Massachusetts 02110

Fax: (617) 951-7050

Attention: Marc A. Rubenstein, Esq.

          If to the Trustee:

 

 

 

 

     The Company or the Trustee by written notice to the other may designate additional or
different addresses for subsequent notices or communications. Any notice or communication to the
Company or the Trustee shall be deemed to have been given or made as of the date so delivered if
personally delivered; when receipt is confirmed by telephone or electronic

-40-

 

transmission report, if sent by facsimile; and three Business Days after mailing if sent by
registered or certified mail, postage prepaid (except that a notice of change of address shall not
be deemed to have been given until actually received by the addressee).

     Any notice or communication mailed to a Securityholder shall be mailed to such Securityholder
by first-class mail, postage prepaid, at such Securityholder’s address shown on the register kept
by the Registrar.

     Failure to mail, or any defect in, a notice or communication to a Securityholder shall not
affect its sufficiency with respect to other Securityholders. If a notice or communication to a
Securityholder is mailed in the manner provided above, it shall be deemed duly given, three
Business Days after such mailing, whether or not the addressee receives it.

     In case by reason of the suspension of regular mail service, or by reason of any other cause,
it shall be impossible to mail any notice as required by this Indenture, then such method of
notification as shall be made with the approval of the Trustee shall constitute a sufficient
mailing of such notice.

     In the case of Global Securities, notices or communications to be given to Securityholders
shall be given to the Depository, in accordance with its applicable policies as in effect from time
to time.

     In addition to the manner provided for in the foregoing provisions, notices or communications
to Securityholders shall be given by the Company by release made to Reuters Economic Services and
Bloomberg Business News.

10.3. COMMUNICATIONS BY HOLDERS WITH OTHER HOLDERS.

     Securityholders of any Series may communicate pursuant to TIA Section 312(b) with other
Securityholders of that Series or any other Series with respect to their rights under this
Indenture or the Securities of that Series or any other Series. The Company, the Trustee, the
Registrar and any other Person shall have the protection of TIA Section 312(c).

10.4. CERTIFICATE AND OPINION AS TO CONDITIONS PRECEDENT.

     Upon any request or application by the Company to the Trustee to take any action under this
Indenture, the Company shall furnish to the Trustee:

          (1) an Officers’ Certificate (which shall include the statements set forth in Section 10.5
below) stating that, in the opinion of the signers, all conditions precedent, if any, provided for
in this Indenture relating to the proposed action have been complied with; and

          (2) an Opinion of Counsel (which shall include the statements set forth in Section 10.5 below)
stating that, in the opinion of such counsel, all such conditions precedent have been complied
with.

-41-

 

10.5. STATEMENT REQUIRED IN CERTIFICATE AND OPINION.

     Each certificate and opinion with respect to compliance with a condition or covenant provided
for in this Indenture (other than pursuant to Section 4.4) shall include:

          (1) a statement that the Person making such certificate or opinion has read such covenant or
condition;

          (2) a brief statement as to the nature and scope of the examination or investigation upon
which the statements or opinions contained in such certificate or opinion are based;

          (3) a statement that, in the opinion of such Person, it or he has made such examination or
investigation as is necessary to enable it or him to express an informed opinion as to whether or
not such covenant or condition has been complied with; and

          (4) a statement as to whether or not, in the opinion of such Person, such covenant or
condition has been complied with.

10.6. RULES BY TRUSTEE AND AGENTS.

     The Trustee may make reasonable rules for action by or at meetings of Securityholders. The
Registrar and Paying Agent may make reasonable rules for their functions.

10.7. BUSINESS DAYS; LEGAL HOLIDAYS; PLACE OF PAYMENT.

     A “Business Day” is a day that is not a Legal Holiday. A “Legal Holiday” is a Saturday, a
Sunday, a federally-recognized holiday or a day on which banking institutions are not authorized or
required by law, regulation or executive order to be open in the State of New York.

     If a payment date is a Legal Holiday at a Place of Payment, payment may be made at that place
on the next succeeding day that is not a Legal Holiday, and no interest shall accrue for the
intervening period. “Place of Payment” means the place or places where the principal of, and
interest and premium, if any, on, the Securities of a Series are payable as specified as
contemplated by Section 2.2. If the regular record date is a Legal Holiday, the record date shall
not be affected.

10.8. GOVERNING LAW.

     THIS INDENTURE AND THE SECURITIES SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE
LAWS OF THE STATE OF NEW YORK, AS APPLIED TO CONTRACTS MADE AND PERFORMED WITHIN THE STATE OF NEW
YORK WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAW.

-42-

 

10.9. NO ADVERSE INTERPRETATION OF OTHER AGREEMENTS.

     This Indenture may not be used to interpret another indenture, loan, security or debt
agreement of the Company or any Subsidiary thereof. No such indenture, loan, security or debt
agreement may be used to interpret this Indenture.

10.10. NO RECOURSE AGAINST OTHERS.

     A director, officer, employee, stockholder or incorporator, as such, of the Company shall not
have any liability for any obligations of the Company under the Securities or the Indenture. Each
Securityholder by accepting a Security waives and releases all such liability. Such waiver and
release are part of the consideration for the issuance of the Securities.

10.11. SUCCESSORS.

     All covenants and agreements of the Company in this Indenture and the Securities shall bind
the Company’s successors and assigns, whether so expressed or not. All agreements of the Trustee,
any additional trustee and any Paying Agents in this Indenture shall bind their respective
successors and assigns.

10.12. MULTIPLE COUNTERPARTS.

     The parties may sign multiple counterparts of this Indenture. Each signed counterpart shall
be deemed an original, but all of them together represent one and the same agreement.

10.13. TABLE OF CONTENTS, HEADINGS, ETC.

     The table of contents, cross-reference sheet and headings of the Articles and Sections of this
Indenture have been inserted for convenience of reference only, are not to be considered a part
hereof, and shall in no way modify or restrict any of the terms or provisions hereof.

10.14. SEVERABILITY.

     Each provision of this Indenture shall be considered separable, and if for any reason any
provision which is not essential to the effectuation of the basic purpose of this Indenture or the
Securities shall be invalid, illegal or unenforceable, the validity, legality and enforceability of
the remaining provisions shall not in any way be affected or impaired thereby, and a Holder shall
have no claim therefor against any party hereto.

10.15. SECURITIES IN A FOREIGN CURRENCY OR IN EUROS.

     Unless otherwise specified in a Board Resolution, a supplemental indenture hereto or an
Officers’ Certificate delivered pursuant to Section 2.2 with respect to a particular Series of
Securities, whenever for purposes of this Indenture any action may be taken by the Holders of a
specified percentage in aggregate principal amount of Securities of all Series or all Series
affected by a particular action at the time outstanding and, at such time, there are outstanding
Securities of any Series which are denominated in a coin or currency other than Dollars (including
Euros), then the principal amount of Securities of such Series which shall be deemed

-43-

 

to be outstanding for the purpose of taking such action shall be that amount of Dollars that
could be obtained for such amount at the Market Exchange Rate at such time. For purposes of this
Section 10.15, “Market Exchange Rate” shall mean the noon Dollar buying rate in New York City for
cable transfers of that currency as published by the Federal Reserve Bank of New York; PROVIDED,
HOWEVER, in the case of Euros, Market Exchange Rate shall mean the rate of exchange determined by
the Commission of the European Union (or any successor thereto) as published in the Official
Journal of the European Union (such publication or any successor publication, the “Journal”). If
such Market Exchange Rate is not available for any reason with respect to such currency, the
Trustee shall use, in its sole discretion and without liability on its part, such quotation of the
Federal Reserve Bank of New York or, in the case of Euros, the rate of exchange as published in the
Journal, as of the most recent available date, or quotations or, in the case of Euros, rates of
exchange from one or more major banks in New York City or in the country of issue of the currency
in question or, in the case of Euros, in Luxembourg or such other quotations or, in the case of
Euros, rates of exchange as the Trustee, upon consultation with the Company, shall deem
appropriate. The provisions of this paragraph shall apply in determining the equivalent principal
amount in respect of Securities of a Series denominated in currency other than Dollars in
connection with any action taken by Holders of Securities pursuant to the terms of this Indenture.

     All decisions and determinations of the Trustee regarding the Market Exchange Rate or any
alternative determination provided for in the preceding paragraph shall be in the Trustee’s sole
discretion, and shall, in the absence of manifest error, be conclusive to the extent permitted by
law for all purposes and irrevocably binding upon the Company and all Holders.

10.16. JUDGMENT CURRENCY.

     The Company agrees, to the fullest extent that it may effectively do so under applicable law,
that (a) if for the purpose of obtaining judgment in any court it is necessary to convert the sum
due in respect of the principal of, or interest or premium, if any, or other amount on, the
Securities of any Series (the “Required Currency”) into a currency in which a judgment will be
rendered (the “Judgment Currency”), the rate of exchange used shall be the rate at which, in
accordance with normal banking procedures, the Trustee could purchase in The City of New York the
Required Currency with the Judgment Currency on the day on which final unappealable judgment is
entered, unless such day is not a Business Day, in which instance, the rate of exchange used shall
be the rate at which, in accordance with normal banking procedures, the Trustee could purchase in
The City of New York the Required Currency with the Judgment Currency on the Business Day preceding
the day on which final unappealable judgment is entered and (b) its obligations under this
Indenture to make payments in the Required Currency (i) shall not be discharged or satisfied by any
tender or any recovery pursuant to any judgment (whether or not entered in accordance with
subsection (a)) in any currency other than the Required Currency, except to the extent that such
tender or recovery shall result in the actual receipt, by the payee, of the full amount of the
Required Currency expressed to be payable in respect of such payments, (ii) shall be enforceable as
an alternative or additional cause of action for the purpose of recovering in the Required Currency
the amount, if any, by which such actual receipt shall fall short of the full amount of the
Required Currency so expressed to be payable and (iii) shall not be affected by judgment being
obtained for any other sum due under this Indenture.

-44-

 

     IN WITNESS WHEREOF, the parties hereto have caused this Indenture to be duly executed, and
their respective corporate seals to be hereunto affixed and attested, all as of the day and year
first above written.

	 	 	 	 	 
	 

	 	RXI PHARMACEUTICALS CORPORATION	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 

Name:
	 	 
	 

	 	 
 	 	 
	 

	 	Title:	 	 
	 

	 	 
 	 	 
	 
	 	 	 	 
	 

	 	[Name of Trustee]	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 
 	 	 
	 

	 	Name:	 	 
	 

	 	 
 	 	 
	 

	 	Title:	 	 
	 

	 	 
 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 
 	 	 
	 

	 	Name:	 	 
	 

	 	 
 	 	 
	 

	 	Title:	 	 
	 

	 	 
 	 	 

-45-EX-10.1

EXHIBIT 10.1

EMPLOYMENT AGREEMENT

          THIS EMPLOYMENT AGREEMENT (together with its Exhibits, this “Agreement”) is made as of the
22nd day of May, 2008 (the “Signing Date”), by and between CNA Financial Corporation, a
Delaware corporation (together with its successors and assigns, the “Company”), and Thomas F.
Motamed (the “Executive”, and, together with the Company, a “Party”);

W I T N E S S E T H:

          WHEREAS, the Company wishes to employ the Executive as the Chairman of the Board, and as the
Chief Executive Officer, of the Company and of its wholly-owned insurance subsidiaries (the “CNA
Insurance Companies,” and together with the Company, the “CNA Companies”) following the expiration
of certain non-compete and non-solicitation obligations to his current employer; and the Executive
wishes to accept, as of the Commencement Date, and agrees to such employment under the terms and
conditions set forth herein.

          NOW, THEREFORE, in consideration of the foregoing premises and the promises and covenants
herein, the Parties agree as follows:

	1.	 	Employment Term. The Company shall employ the Executive under this Agreement, and the
Executive shall accept such employment, for the Term. The “Term” shall commence on Monday,
June 8, 2009 or such other date as the Parties may agree upon in writing (the “Commencement
Date”) and shall end on December 31, 2013, subject to annual renewals thereafter, if any,
upon mutual written agreement by the Parties. Notwithstanding the foregoing, the
Executive’s employment hereunder, and the Term, may be terminated at any time in accordance
with Section 6 below.
	 
	2.	 	Duties of the Executive and Place of Business.

	 	(a)	 	Throughout the Term, the Executive shall serve as a member of the Company’s
Board, as the Chairman of such Board, and as the Chief Executive Officer of the Company
(if elected to such positions by the Board, as is the intention of the Parties).
Throughout the Term, the Executive shall also serve as the Chairman of the Board, and
the Chief Executive Officer, of each of the CNA Insurance Companies, and of such other
Affiliates of the Company as the Parties may from

 

 

	 	 	 	time to time agree upon in writing. As the Chief Executive Officer of the Company,
the Executive shall have all authorities, duties and responsibilities customarily
exercised by an individual serving in that position at an entity of the size and
nature of the Company (including, without limitation, responsibility for the day to
day operations of the CNA Insurance Companies and for development and implementation
of the CNA Insurance Companies’ business plans and strategies); shall be assigned no
duties or responsibilities that are materially inconsistent with, or that materially
impair his ability to discharge, the foregoing duties and responsibilities; shall
have such additional duties and responsibilities, consistent with the foregoing, as
may be from time to time reasonably be assigned to him by the Company’s Board; and
shall report solely and directly to the Company’s Board. For purposes of this
Agreement, “Affiliate” of a Person shall mean any Person that directly or indirectly
controls, is controlled by, or is under common control with, such Person; “Board”
shall mean, in the case of a corporation, the board of directors of such corporation
and, in the case of any other entity, the corresponding governing Person; and
“Person” shall mean any individual, corporation, partnership, limited liability
company, joint venture, trust, estate, board, committee, agency, body, employee
benefit plan, or other person or entity. Notwithstanding the foregoing, for all
purposes of this Agreement (except Sections 6.3(b)(ii), 6.7(x), 7, 18(a), 24 and 25
and Exhibit A), the term Affiliate shall not include Loews Corporation or any of its
direct or indirect subsidiaries (other than the Company and the Company’s
subsidiaries).
	 
	 	(b)	 	Throughout the Term, the Executive: shall diligently and to the best of his
abilities assume, perform, and discharge his duties and responsibilities hereunder as
the Chairman of the Board, and the Chief Executive Officer, of the Company, and the CNA
Insurance Companies; and shall devote substantially all of his business time and effort
to the business and affairs of the Company and its subsidiaries. However, nothing in
this Agreement or elsewhere shall preclude the Executive from: (i) engaging in civic,
charitable or community services; (ii) devoting a reasonable amount of time to private
investments and personal affairs; or (iii) serving, with the prior approval of the
Company’s Board, on the boards of for-profit entities, so long as such activities or
services do not interfere with the Executive’s responsibilities to the Company.
	 
	 	(c)	 	The Executive shall establish a residence in the Chicago metropolitan area not
later than five (5) days following the Commencement Date and shall maintain such a
residence during the Term. The Executive’s principal place of business shall be at the
Company’s headquarters in Chicago. As soon as practicable

2

 

	 	 	 	following the Commencement Date, but no later than ten (10) days following the
Commencement Date the Company shall pay the Executive $250,000 in recognition of the
expense of establishing and maintaining a Chicago metropolitan area residence.

	3.	 	Compensation.

	 	(a)	 	Beginning as of the Commencement Date, the Company shall pay the Executive for
the period he is employed by the Company hereunder an annualized base salary of
$1,000,000.00 (the “Base Salary”). The Base Salary shall be paid in accordance with
the regular payroll practices applicable to senior executives of the Company generally,
but no less frequently than monthly. At the discretion of the Company’s Board, or of
the compensation committee of such Board (the “Committee”), the annualized Base Salary
may be increased annually during the Term of the Agreement, beginning in calendar year
2010. The Base Salary shall not be decreased at any time, or for any purpose, during
the Term (including, without limitation, for the purpose of determining benefits due
under Section 6) without the Executive’s prior written consent.

	 	(b)	 	(i)	 	For each calendar year (a “Performance Year”) that ends during the Term,
the Executive shall be entitled to receive an annual incentive cash award (an “Annual
Bonus”) under the CNA Financial Corporation 2000 Incentive Compensation Plan (the
“Plan”) to the extent that the criteria set forth in this Section 3(b) are satisfied
for such year.

	 	(ii)	 	For each full Performance Year during the Term, the Annual
Bonus shall equal 1.2% of NOI (as described below) for such year;
provided, however, that, for any such year, the Executive’s target
Annual Bonus shall not be less than $2,500,000, and his maximum Annual Bonus
shall not be more than $4,000,000. For purposes of this Agreement, “NOI” for
any Performance Year or quarter shall mean the Company’s net income for such
Performance Year or quarter, as adjusted in good faith by the Committee for
such Performance Year or quarter for the purpose of determining annual bonuses
for senior executives of the Company generally. For any Performance Year or
quarter, NOI shall be determined on a basis that is no less favorable to the
Executive than to other senior executive officers of the Company generally.
The Committee may exercise negative discretion under the Plan to decrease or
eliminate any

3

 

	 	 	 	portion of the Executive’s Annual Bonus for any Performance Year that
exceeds his Annual Bonus target of $2,500,000.
	 
	 	(iii)	 	For the first Performance Year that ends during the Term, the
Executive’s Annual Bonus shall equal 1.2% of the sum of (x) the Company’s NOI
for each calendar quarter during such year that commences after the
Commencement Date plus (y) a pro-rata portion of the Company’s NOI for the
calendar quarter in which the Commencement Date occurs, such pro-rata portion
to be determined by multiplying the Company’s NOI for such quarter by a
fraction, the numerator of which is the number of calendar days during such
quarter that the Executive is employed hereunder and the denominator of which
is the number of calendar days in such quarter (the “Quarterly Proration
Fraction”). The target Annual Bonus payment for such year, above which the
Committee may exercise negative discretion, shall be determined by multiplying
$2,500,000 times a fraction, the numerator of which is the number of calendar
days during such year that the Executive is employed hereunder and the
denominator of which is 365 (the “Yearly Proration Fraction”). The maximum
Annual Bonus payment for such year shall be determined by multiplying
$4,000,000 by the Yearly Proration Fraction.
	 
	 	(iv)	 	Annual Bonus payments shall be made to the Executive in cash no
later than corresponding bonus payments are made to senior executive officers
of the Company generally, and in no event later than 70 days after the end of
the Performance Year to which they relate. In the event that the Company
ceases to maintain an annual bonus program that is based on NOI and that is
similar to the program in effect as of the Signing Date, a new program shall be
established under which the Executive shall have an annual target bonus of at
least $2,500,000.

	 	(c)	 	(i)	 	The Executive shall be entitled to participate in the Company’s long term
incentive cash award program, under the Plan, for each of the three-calendar-year
performance periods (each, a “Performance Period”) that include any calendar year that
begins or ends during the Term (each a “Covered Year”), but only to the extent provided
in this Agreement. For each Covered Year in each such Performance Period, the
Executive shall be entitled to receive a long term incentive cash award under the Plan
(a “Long Term Bonus”) to the extent that the Company achieves

4

 

	 	 	 	performance objectives established by the Committee for such Covered Year,
on terms and conditions consistent with this Agreement and no less favorable
to the Executive than those applying to senior executive officers of the
Company generally. For each Covered Year, and except to the extent
otherwise provided in Section 3(c)(ii), the Executive’s target long term
incentive cash award for each of the three Performance Periods that are then
ongoing shall be eight and one-third percent (8-1/3%) of his annualized Base
Salary as in effect on the last day of such year, and his maximum long term
incentive cash award shall be sixteen and two thirds percent (16-2/3%) of
such annualized Base Salary. Except to the extent otherwise provided in
Section 6, the Executive shall not be entitled to any Long Term Bonus for
any calendar year that ends after the Termination Date (as defined below),
except to the extent that the terms and conditions of corresponding awards
to other senior executives generally provide for long term incentive award
payments for such year in corresponding circumstances.
	 
	 	(ii)	 	Notwithstanding the foregoing, the Long Term Bonus that the
Executive shall be entitled to receive with respect to the Covered Year during
which the Commencement Date occurs shall, for each of the three Performance
Periods that is then ongoing, be determined by multiplying the Long Term Bonus
to which he would have been entitled under Section 3(c)(ii) had he participated
in such Performance Period from the beginning of such Covered Year by a
fraction: (i) the numerator of which is the sum of (a) the Company’s
achievement of the applicable performance measure for each of the full calendar
quarters in such Covered Year that began after the Commencement Date and (b)
the Company’s achievement of the applicable performance measure for the
calendar quarter in which the Commencement Date occurs multiplied by the
Quarterly Proration Fraction, and (ii) the denominator of which is the actual
performance for such Covered Year. With respect to each of such Performance
Periods, the Executive’s target long term bonus for such Covered Year shall be
eight and one-third percent (8-1/3%) of his annualized Base Salary as in effect
on the last day of such year, and his maximum long term bonus shall be sixteen
and two thirds percent (16-2/3 %) of such Base Salary, in each case as
multiplied by the Yearly Proration Fraction.
	 
	 	(iii)	 	Long Term Bonus payments for each Covered Year and each
Performance Period under this Section 3(c) shall be made in cash no later than
the

5

 

	 	 	 	time(s) at which corresponding bonus payments are made to other senior
executive officers of the Company generally. In the event that the long
term bonus program that is in effect as of the Signing Date is discontinued
with respect to any Covered Year, a new program shall be established under
which the Executive has an aggregate target long term incentive cash bonus
opportunity for such Covered Year, after taking into account all performance
periods that are then ongoing (including performance periods that may be
on-going under the former program), that equals at least 25 percent (25%) of
his annualized Base Salary as in effect on the last day of the such Covered
Year, and that is otherwise on terms and conditions not less favorable to
the Executive than those that would have applied if the old program had
remained in effect.

	 	(d)	 	During the Term, the Executive shall be granted stock appreciation rights
(“SARs”) under the Plan at a rate of 80,000 SARs per calendar year (such number being
subject to adjustment under Section 3(j) below). The initial grant shall be made on
the Commencement Date and shall be pro-rated by multiplying 80,000 (such number being
subject to adjustment under Section 3(j) below) by the Yearly Proration Fraction.
Subsequent grants shall be made during the first quarter of each calendar year that
commences during the Term and shall be made at a time, and on terms and conditions,
that are consistent with this Agreement and otherwise no less favorable to the
Executive than those that apply to corresponding grants to other senior executive
officers of the Company. Each of the SARs shall have an exercise price equal to the
fair market value of a share of the Company’s common stock on the date of grant; shall
have a term of ten years; shall be settled in stock (or, at the Company’s election, in
cash); and shall vest, and hence become both exercisable and non-forfeitable, in equal
annual installments on each of the first four anniversaries of the date of grant,
provided that the Executive is employed by the Company on such date, except as
otherwise provided in this Agreement. All rights with regard to unvested SARs shall,
except to the extent otherwise provided in Section 6, terminate upon termination of the
Executive’s employment with the Company. The annual grant of SARs to the Executive may
be increased at the recommendation, and with the approval, of the Committee, subject to
share availability.

	 	(e)	 	(i)	 	On the Commencement Date, the Executive shall be granted restricted stock
units (“RSUs”), each representing the right to receive one share of the Company’s
common stock, having a value of $2,500,000, based upon the volume weighted average
price during the ten (10) trading days

6

 

	 	 	 	immediately preceding the date of grant (the “VWAP”). Notwithstanding the
foregoing, the Executive shall be granted RSUs under this Section 3(e)(i)
with respect to no more than 100,000 shares (such number being subject to
adjustment under Section 3(j), below); provided, however, that in no
event shall the RSUs granted under this Section 3(e)(i) have a value, based
on the VWAP, that is less than $2,000,000.
	 
	 	(ii)	 	Each calendar year during the Term, the Executive shall be
granted RSUs having a value of $2,500,000 on the date of grant, based upon the
VWAP. The first grant shall be made on the Commencement Date and shall be
pro-rated (i.e., shall have a date of grant value equal to $2,500,000
times the Yearly Proration Fraction). The Company shall provide to the
Executive a copy of the award documents that are to govern this first grant, as
well as those that are to govern his initial grant of SARs and his grant of
RSUs under Section 3(e)(i), no later than twenty-one (21) days prior to the
Commencement Date. Subsequent grants of RSUs shall be made during the first
quarter of each calendar year that commences during the Term and on the same
date as SARs are granted to the Executive under Section 3(d), and shall be made
on terms and conditions that are consistent with this Agreement and otherwise
no less favorable to the Executive than those that apply to corresponding
grants to other senior executive officers of the Company. Each grant shall be
earned to the extent (and only to the extent) provided in the table below,
where NOI shall have the same definition as under Section 3(b)(ii) above, and
Budgeted NOI shall mean the Company’s budgeted net income as in effect at the
time of the applicable grant, as later adjusted by the Committee in the same
manner in which the Company adjusts net income to compute NOI, in each case
with respect to the calendar year in which the grant is made.

	 	 	 	 	 
	 	 	% of RSUs
	NOI as a % of Budgeted NOI	 	Earned
	less than 50%
	 	 	0	%
	50% - 100%
	 	 	80	%
	above 100%
	 	 	100	%

	 	(iii)	 	All RSUs granted pursuant to Section 3(e)(i), and all RSUs
that have been earned pursuant to Section 3(e)(ii), shall vest (and thus become
non-forfeitable) in equal installments on each of the first four anniversaries
of the date of grant, provided that the Executive is employed by the Company on
such date, except as otherwise provided in this Agreement.

7

 

	 	 	 	All RSUs shall be settled in stock promptly after vesting, but in no event
more than thirty (30) days after vesting.
	 
	 	(iv)	 	All rights with regard to unvested RSUs (including RSUs that
have not yet been earned) shall, except to the extent otherwise provided in
Section 6, terminate upon termination of the Executive’s employment with the
Company. The annual grant of RSUs to the Executive may be increased at the
recommendation, and with the approval, of the Committee, subject to share
availability.
	 
	 	(v)	 	Upon the Company’s payment of a cash dividend in respect of its
outstanding Company common stock, the Executive shall be credited with dividend
equivalents in respect of each RSU outstanding on the record date for such
dividend. Such dividend equivalents shall be equal to the dividend paid on an
outstanding share of common stock and shall be credited as of the dividend
payment date until the respective outstanding RSU becomes vested, at which time
such dividend equivalent right shall be paid to the Executive, without
interest, in cash.

	 	(f)	 	For purposes of determining the Executive’s entitlements under the CNA Savings
& Capital Accumulation Plan (“S-CAP”), the CNA Supplemental Savings & Capital
Accumulation Plan (“SES-CAP”), and their successors (collectively, the “Savings
Plans”), the Executive’s pensionable earnings (e.g., both his “Compensation”,
and his “Retirement Plan Compensation”, as defined under the SES-CAP) shall be deemed
to include both his Base Salary when paid, and his Annual Bonus on the earlier of the
date it is actually paid and the date it would have been paid in the absence of any
elective deferral by the Executive, provided that the aggregate amount of salary and
annual bonus deemed included for any full calendar year shall not exceed $3,500,000.
With respect to the calendar year in which the Commencement Date occurs such amount
shall be determined by multiplying $3,500,000 by the Yearly Proration Fraction.
	 
	 	(g)	 	Provided that the Executive is employed hereunder on December 31, 2013, (i) the
Company shall pay $15,000 to the Executive in each succeeding January, commencing in
January 2014, and ending with the payment made in January 2033, and (ii) the Company
shall pay to the Executive within 30 days following termination of his employment
hereunder a lump sum payment equal to $1,500,000 plus (if such employment ends after
January 1, 2014) interest at a rate

8

 

	 	 	 	of 5% per annum from January 1, 2014 until the date of payment. The benefits
provided under this Section 3(g) shall be in addition to any benefits to which the
Executive becomes entitled under any current or future savings or retirement plan or
arrangement of the Company or its Affiliates.
	 
	 	(h)	 	All payments due to the Executive under this Agreement shall be subject to
withholding as required by law or as authorized by the Executive in writing.
	 
	 	(i)	 	It is the Parties’ intention that all payments, benefits and entitlements
received by the Executive be provided in a manner that does not impose any additional
taxes, interest or penalties on the Executive with respect to such payments, benefits
and entitlements under Section 409A of the Code, and its implementing regulations
(“Section 409A”). Each of the Parties has used, and will continue to use, its best
reasonable efforts to avoid the imposition of such additional taxes, interest or
penalties, and the Parties agree to work together in good faith to amend this
Agreement, and to structure any payment, benefit or other entitlement received by the
Executive, in a manner that avoids imposition of such additional taxes, interest or
penalties while preserving the affected payment, benefit or entitlement to the extent
practicable and maintaining the basic financial provisions of this Agreement. For
purposes of this Agreement, “Code” shall mean the Internal Revenue Code of 1986, as
amended, and any reference to a particular section of the Code shall include any
provision that modifies, replaces or supersedes such section.
	 
	 	(j)	 	If any merger, consolidation, reorganization, recapitalization, spin-off,
split-up, combination, exchange of securities, modification of securities, share split,
reverse share split, share dividend, other distribution of securities or other property
in respect of shares or other securities, or other change in corporate structure or
capitalization affecting the rights or value of securities of any class that is to be
subject to an SAR grant under Section 3(d), or an RSU grant under Section 3(e)(i) (but
only to the extent that the 100,000 share cap applies), occurs (i) on or after the
Signing Date and (ii) on or before the date that such grant is awarded, then
appropriate adjustment(s) shall be made in the number and/or kind of securities to be
subject to such grant, so as to avoid dilution or enlargement of the rights, economic
opportunity and value intended to be represented by such grant.

9

 

	 	(k)	 	The Committee, or the Company, shall structure and administer all awards to the
Executive under Section 3(b), 3(c), 3(d) and 3(e) hereof in such a manner as to
preserve deductibility under Section 162(m) of the Code, provided that the Executive’s
rights hereunder are not adversely affected.

	4.	 	Other Benefits. During the Term, the Executive shall be entitled to participate in all
benefit and prerequisite plans, programs and arrangements of the Company and its Affiliates
that are made available to senior executives of the Company generally, in each case on terms
and conditions no less favorable to the Executive than those that apply to other senior
executives of the Company generally. The Executive’s entitlement to participate in any such
plan, program or arrangement shall, in each case, be subject to the terms and conditions of
such plan, program or arrangement that apply to senior executives of the Company generally.
For each calendar year that commences or ends during the Term, the Executive shall be
entitled to reimbursement for tax return preparation, and for not more than one personal
club membership if used primarily for business purposes. During the Term, the Executive
shall be entitled to use the Company aircraft for personal use consistent with the Company’s
practice for its Chief Executive Officer as in effect on the Signing Date and for a maximum
of sixty (60) hours per calendar year (pro-rated for partial years), with imputed taxable
income to the Executive for such personal use of the Company aircraft. If the Company
adopts a paid time off policy during the term that is applicable to the Executive, he shall
be deemed to have twenty (20) years of service at the Company as of the Commencement Date
for all purposes under such policy and shall be treated no less favorably under such policy
than any other senior executive of the Company.
	 
	5.	 	Expense Reimbursement.

	 	(a)	 	The Executive shall be entitled to prompt reimbursement by the Company for all
reasonable and customary travel and other business expenses he incurs in connection
with carrying out his duties under this Agreement, in accordance with the general
travel and business reimbursement policies then applying to senior executives of the
Company generally. The Executive shall report all such expenditures not less
frequently than monthly, accompanied by adequate records and such other documentary
evidence as required by the Company or by Federal or state tax statutes or regulations
governing the substantiation of such expenditures.

10

 

	 	(b)	 	As soon as practicable following the Commencement Date, the Company shall
reimburse the Executive for all appropriately documented attorneys’ fees and other
charges of counsel he incurred in entering into, and implementing, this Agreement,
provided, however, that the amount reimbursed under this Section 5(b) shall not
exceed $130,000.

	6.	 	Termination of Employment
	 
	6.1	 	Death and Disability

	 	(a)	 	In the event that the Executive’s employment hereunder terminates due to his
death or Permanent Disability (as defined below), the Term shall expire, and he shall
be entitled to the following:

	 	(i)	 	Continued payment of the Base Salary, at the rate in effect as
of the date his employment hereunder terminates (the “Termination Date”) and
with payment at the times the Base Salary would have been paid in accordance
with the Company’s normal payroll practices, for (x) in the case of termination
due to death, ninety (90) days following the Termination Date or (y) in the
case of termination due to Permanent Disability, through December 31, 2013 or,
if the termination due to Permanent Disability is after December 31, 2013,
through the end of the then scheduled Term; provided, however, that in
the case of termination due to Permanent Disability, the Base Salary paid to
the Executive for any month shall be offset by the amount of any gross periodic
disability benefits (other than benefits attributable to his own unreimbursed
contributions) that he receives during such month under any disability
insurance plan or program of the Company or its Affiliates.
	 
	 	(ii)	 	A Pro-Rata Annual Bonus (as defined below), and a Pro-Rata Long
Term Bonus (as defined below), for the calendar year of termination.
	 
	 	(iii)	 	Full vesting, as of the Termination Date, of all outstanding
SARs, each such SAR to remain exercisable for at least the lesser of three
years following the Termination Date and the remainder of its maximum stated
term; full vesting, as of the Termination Date, of any outstanding RSU whose
vesting is based solely on continued employment; full vesting of

11

 

	 	 	 	any outstanding RSU granted pursuant to Section 3(e)(ii) in the calendar
year of termination or in the previous year, subject solely to satisfying
the performance criteria governing such RSU; and full vesting, as of the
Termination Date, of any other outstanding equity-based award (other than
SARs and RSUs).
	 
	 	(iv)	 	In the event such termination of employment occurs prior to
December 31, 2013, the payments described in Section 3(g)(i) and the lump sum
payment described in Section 3(g)(ii), with the payments described in Section
3(g)(i) to be made at the times they would have been made if the Executive had
been employed hereunder on December 31, 2013 and the lump sum payment described
in Section 3(g)(ii) to be made within 30 days following the Termination Date.
	 
	 	(v)	 	The Executive and his dependents shall be entitled to continued
participation for a period of thirty (30) months following the Termination Date
(which shall be concurrent with any health care continuation benefits under
COBRA), in all medical, dental, vision, prescription drug, hospitalization,
life insurance, disability and other welfare benefit coverages and benefits in
which they were participating as of such date, on terms and conditions that are
no less favorable to them than those that applied as of such date.
	 
	 	(vi)	 	The benefits described in Section 6.6 below.

	 	(b)	 	For purposes of this Agreement, the term “Permanent Disability” shall mean that
the Executive has been unable, due to physical or mental incapacity, to substantially
perform his duties and responsibilities under this Agreement for 180 days out of any
270 consecutive days.
	 
	 	(c)	 	For purposes of this Agreement, “Pro-Rata Annual Bonus,” when used in respect
of a Performance Year, shall mean an amount equal to 1.2% of the sum of (x) the
Company’s NOI for each full calendar quarter during such year that ends on or before
the Termination Date plus (y) in the event that the Termination Date is not the last
calendar day of a calendar quarter, a pro-rata portion of the Company’s NOI for the
calendar quarter in which the Termination Date occurs, such pro-rata portion to be
determined by multiplying the Company’s NOI for

12

 

	 	 	 	such quarter by the Quarterly Proration Fraction. The Committee may exercise
negative discretion with respect to amounts in excess of the target Pro-Rata Annual
Bonus amount, which amount shall be determined by multiplying $2,500,000 times the
Yearly Proration Fraction. The maximum Pro-Rata Annual Bonus shall be determined by
multiplying $4,000,000 by the Yearly Proration Fraction. Any Pro-Rata Annual Bonus
shall be paid as promptly as reasonably practicable after the last day of the
calendar quarter in which the Termination Date occurs, but in no event more than
thirty (30) days after such last day.
	 
	 	(d)	 	For purposes of this Agreement, “Pro-Rata Long Term Bonus”, when used in
respect of a calendar year, shall mean the amount obtained by multiplying (x) the sum
of the Long Term Bonuses that the Executive would have received for such year with
respect to each performance period that is then ongoing if he had remained employed
hereunder through the end of such year (assuming for this purpose that his annualized
Base Salary at the end of such year would have been equal to his annualized Base Salary
as of the Termination Date) times (y) the Yearly Proration Fraction. Each of the
prorated amounts that constitute the Pro-Rata Long Term Bonus shall be paid on the date
that the corresponding Long Term Bonus would have been paid if the Executive’s
employment hereunder had not terminated.

	6.2	 	Termination for Cause by the Company.

	 	(a)	 	The Company may terminate the Executive’s employment hereunder for Cause.
Prior to any such termination of employment for Cause, the Company shall provide the
Executive with written notice from the Company’s Board stating in reasonable detail the
particular circumstances that constitute the grounds on which the termination for Cause
is based (the “Cause Notice”). The Executive shall then be entitled to a hearing at a
duly convened meeting of the Company’s Board, at which he may be accompanied by counsel
of his choice, provided that he submits a request for a hearing within four (4)
business days after he receives the Cause Notice. Within four (4) business days
following such request the Board shall hold such hearing, which shall last no more than
one (1) business day, and within four (4) business days following such hearing the
Company’s Board shall give written notice to the Executive stating whether, in the
judgment of at least two thirds of the members of the Company’s Board (other than the
Executive), Cause for terminating his employment on the basis set forth in the original
Cause Notice exists. Upon such notice from such Board, the Executive’s employment

13

 

	 	 	 	hereunder shall terminate for Cause, subject to de novo review of
such Board’s determination, through arbitration in accordance with Section 24, if
the Executive so chooses. For avoidance of doubt, the arbitrators shall have no
right to order reinstatement of the Executive’s employment. The Company’s Board may
suspend the Executive from his duties under this Agreement for up to 30 days
following the delivery of any Cause Notice to the Executive, and no such suspension
shall by itself constitute grounds for a Good Reason termination.
	 
	 	(b)	 	In the event that the Executive’s employment hereunder is terminated for Cause
in accordance with Section 6.2(a), the Term shall expire and he shall be entitled only
to the benefits described in Section 6.6 and, notwithstanding anything in this
Agreement to the contrary, the Company shall have no further obligations under Section
19.
	 
	 	(c)	 	For purposes of this Agreement, “Cause” shall mean that: (i) the Executive is
convicted of, or pleads guilty or nolo contendere to, a felony, (ii)
the Executive engages in conduct that constitutes either (x) a material and willful
breach of this Agreement, (y) willful, or reckless, material misconduct in the
performance of the Executive’s duties under this Agreement, or (z) habitual neglect of
the Executive’s material duties under this Agreement; provided, however, that:
(x) in the case of clause (ii) only, such conduct has had a material adverse effect on
the business or prospects of the CNA Companies and (y) for purposes of clauses (ii)(y)
and (ii)(z), Cause shall not include any of the following: bad judgment, negligence, or
any act or omission believed by the Executive in good faith to have been in or not
opposed to the interest of the Company (without any intent by the Executive to gain,
directly or indirectly, a profit to which he is not legally entitled).

	6.3	 	Termination by the Company Without Cause / Termination by the Executive for Good Reason.

	 	(a)	 	In the event that the Executive’s employment hereunder is terminated during the
Term (other than in accordance with Section 6.5) (x) by the Company other
than for Permanent Disability in accordance with Section 6.1 or for Cause in
accordance with Section 6.2 or (y) by the Executive with Good Reason in accordance with
Section 6.3(b), the Term shall expire and he shall be entitled to the following (in
lieu of separation payments under any other Company severance plan, policy or
arrangement):

14

 

	 	(i)	 	Separation payments at a rate of $312,500 per month, commencing
with the month of termination, with such termination payments to be made in
substantially equal installments, not less frequently than monthly, through
December 31, 2013 (or, if Executive’s employment hereunder is terminated after
December 31, 2013, through the end of the then scheduled Term);
provided, however, that such payments shall be made for a period of no
less than six (6) months following the Termination Date.
	 
	 	(ii)	 	The Executive and his dependents shall be entitled to continued
participation, for a period of forty two (42) months following the Termination
Date (which shall be concurrent with any health care continuation benefits
under COBRA), in all medical, dental, vision, prescription drug,
hospitalization, life insurance, disability and other welfare benefit coverages
and benefits in which they were participating as of such date, on terms and
conditions that are no less favorable to them than those that applied as of
such date.
	 
	 	(iii)	 	The benefits described in Sections 6.1(a)(ii), 6.1(a)(iii),
6.1(a)(iv) and 6.6.

	 	(b)	 	“Good Reason” shall mean the occurrence, at any time during the two (2) year
period immediately prior to the Termination Date, of any of the following events,
without the Executive’s prior written consent and without cure by the Company within
thirty (30) days after the Executive gives notice of such event to the Company
requesting cure, such notice to be given within ninety (90) days after the Executive
learns that such event has occurred: (i) the assignment to the Executive of duties that
are materially inconsistent with his position (including his status, offices, titles
and reporting relationships), authority, duties or responsibilities, all as in effect
on the Commencement Date, (ii) actions by the Company or its Affiliates that have
resulted in a substantial diminution in his position, authority, duties or
responsibilities as compared to his position, authority, duties or responsibilities at
the Commencement Date; (iii) a substantial breach by the Company or any of its
Affiliates of any material obligation to the Executive, under this Agreement or
otherwise (e.g., a substantial failure to honor the terms of any material
equity or long term incentive grant, or a material breach of Section 3(a), 3(b), 3(c),
3(d) or 3(e)); (iv) the Company requiring the Executive to be based at any office or
location that is more than 50 miles from the Company’s headquarters in Chicago,
Illinois, as of the Signing Date; (v) any failure to elect or appoint the Executive as
a member of the Company’s Board, Chairman of such

15

 

	 	 	 	Board, and Chief Executive Officer of the Company, as of the Commencement Date, or
to maintain him in such positions throughout the Term (provided, however,
that the Executive need not be elected as, or maintained as, Chairman of the
Company’s Board to the extent that doing so would be a violation of applicable law,
or of applicable rules of the New York Stock Exchange or other self-regulatory
organization to whose rules the Company is subject, and would result in material
harm to the Company); or (vi) any failure of the Company to obtain the assumption in
writing of its obligation to perform this Agreement by any successor to all or
substantially all of the business or assets of the Company within fifteen (15)
calendar days after a merger, consolidation, sale or similar transaction.
	 
	 	(c)	 	Upon termination of his employment hereunder in a termination governed by this
Section 6.3, the Executive shall be entitled to the benefits described in
Section 6.3(a), but only if, except in the case of benefits described in Section 6.6,
he executes, and delivers to the Company within 21 days after the Termination Date (or
such longer period as may reasonably be necessary if the Executive dies or becomes
incapacitated, or if the Company has claimed that the termination is for Cause), a
Release substantially in the form attached hereto as Exhibit A, which Release he does
not revoke during the “Revocation Period” as defined in such Release.
	 
	 	(d)	 	For all purposes of this Agreement, if an Executive Presentment takes place on
the Commencement Date, or within 15 days following the Commencement Date in the event
of extraordinary circumstances, the failure by the Company to employ the Executive on
or within 15 days following the Executive Presentment shall be treated as if the
Executive had become employed hereunder on the date of the Executive Presentment and
had been terminated 15 days later in a termination of employment to which Section
6.3(a) applies. Notwithstanding the foregoing and anything to the contrary in Section
1, if an Executive Presentment does not occur on June 8, 2009 (or such other date as
the Parties may agree upon in writing in accordance with Section 1), then the
Commencement Date shall be the date on which the Executive Presentment occurs. For
purposes of this Agreement, an “Executive Presentment” shall be deemed to have occurred
if (i) the Executive presents himself at the Company’s headquarters prepared to
commence employment and perform his duties hereunder, (ii) the Executive is not subject
to any injunction preventing him from performing his duties hereunder on the date that
he presents himself, and (iii) the Executive has neither been convicted of, nor plead
guilty to, any felony.

16

 

	6.4	 	Voluntary Resignation by the Executive; Failure of Executive Presentment.

	 	(a)	 	In the event that the Executive terminates his employment hereunder prior to
the then-scheduled expiration of the Term on his own initiative, other
than in a termination governed by Section 6.1 or 6.3, the Term shall expire and
he shall be entitled only to the benefits described in Section 6.6 and, notwithstanding
anything in this Agreement to the contrary, the Company shall have no further
obligations under Section 19. A voluntary termination under this Section 6.4 shall not
be deemed a breach of this Agreement. Promptly following any termination of the
Executive’s employment that is governed by this Section 6.4(a), the Company shall
represent that none of the events described in clauses (i) through (vi) of Section
6.3(b) have occurred.
	 
	 	(b)	 	If the Executive terminates his employment hereunder, in a termination governed
by Section 6.4(a), at any time prior to the first anniversary of the Commencement Date,
the Executive shall be required to promptly repay, on an after-tax basis, (i) all
amounts previously paid by the Company to Executive pursuant to Section 2(c) or Section
5(b) and (ii) all amounts that the Company previously advanced pursuant to Section 19.
	 
	 	(c)	 	In the event that an Executive Presentment does not occur in accordance with
Section 6.3(d), then (i) the Term shall not commence, (ii) the Executive shall not be
entitled to any of the benefits described in Section 6.6, (iii) the Company shall have
no further obligations under Section 19, and (iv) Executive shall be required to
promptly repay, on an after-tax basis, (x) all amounts previously paid by the Company
to Executive pursuant to Section 2(c) or Section 5(b) and (y) all amounts that the
Company previously advanced pursuant to Section 19.

	6.5	 	Expiration of Term. Upon the expiration of the Term on December 31, 2013 (or on such
later expiration date as the Parties may have agreed upon in accordance with Section 1), the
Executive’s employment with the Company hereunder shall terminate and the Executive shall be
entitled to the benefits described in Sections 6.1(a)(ii) (but only if the Parties extend
the Term beyond December 31, 2013 in accordance with Section 1), 6.1(a)(iii), 6.1(a)(iv) and
6.6.

17

 

	6.6	 	Any Termination of Employment.

	 	(a)	 	Upon any termination of the Executive’s employment hereunder, he shall be
entitled to:

	 	(i)	 	Unpaid Base Salary through the Termination Date.
	 
	 	(ii)	 	The balance of any unpaid Annual Bonus in respect of any
Performance Year that ended on or before the Termination Date, and the balance
of any unpaid Long Term Bonus with respect to any Covered Year that ended on or
before the Termination Date, in each case paid on the date that it would have
been paid if the Executive’s employment hereunder had not terminated (or, if
such date has already passed, as soon as practicable following the Termination
Date).
	 
	 	(iii)	 	The right to exercise his vested SARs for at least the lesser
of 90 days following the Termination Date and the balance of their maximum
stated term.
	 
	 	(iv)	 	Other or additional benefits in accordance with the then
applicable terms of any applicable Company Arrangement, including, without
limitation, Sections 3, 4, 5, 18, 19, 24 and 25 of this Agreement, and any
equity award grant or agreement, provided that this shall not result in a
duplication of benefits or payments to the Executive or his beneficiaries, as
the case may be.

	 	(b)	 	For purposes of this Agreement, “Company Arrangement” shall mean any plan,
program, corporate governance document, policy, agreement or other arrangement of the
Company or any of its Affiliates.
	 
	 	(c)	 	Upon any termination of his employment hereunder, the Executive shall be deemed
to have resigned from all offices, and Board memberships, that he holds pursuant to
this Agreement, and the Executive agrees to promptly execute any documents reasonably
requested by the Company to evidence or effectuate such resignation.

18

 

	 	(d)	 	Upon any termination of employment hereunder, Executive shall continue to be
bound by the covenants set forth herein at Sections 7 through 15 subsequent to the date
of such termination for such periods of time as provided for in said Sections
respectively.

	6.7	 	No Mitigation; No Offset. In the event of any termination of the Executive’s employment
hereunder, the Executive shall be under no obligation to seek other employment or otherwise
mitigate the obligations of the Company or its Affiliates under this Agreement or otherwise,
and there shall be no offset against amounts or benefits due the Executive under this
Agreement or otherwise on account of (x) any Claim that the Company or any of its Affiliates
may have against him or (y) any remuneration or other benefit earned or received by the
Executive after such termination. Any amounts due under this Section 6 are considered to be
reasonable by the Company and are not in the nature of a penalty.
	 
	6.8	 	Section 409A. Notwithstanding any provision to the contrary in this Agreement or otherwise,
no payment or distribution under this Agreement or otherwise that constitutes an item of
“deferred compensation” under Section 409A and becomes payable by reason of the termination of
the Executive’s employment hereunder shall be made to the Executive unless the termination of
the Executive’s employment constitutes a “separation from service” (as such term is defined in
Section 409A). In addition, no such payment or distribution of deferred compensation shall be
made to the Executive prior to the earlier of (a) the expiration of the six (6) month period
measured from the date of the Executive’s “separation from service” (as such term is defined
in Section 409A), or (b) the date of the Executive’s death, if the Executive is deemed at the
time of such separation from service to be a “specified employee” within the meaning of that
term under Section 409A and if such delayed commencement is otherwise required to avoid
“additional tax” under Section 409A(a)(2) of the Code. All payments and benefits that are
delayed pursuant to the immediately preceding sentence shall be paid to the Executive in a
lump sum upon expiration of such six (6) month period (or if earlier upon the Executive’s
death), together with accrued interest for the period of delay at the rate of 5% per annum.
Any separate payment or benefit under this Agreement or otherwise shall not be “deferred
compensation” subject to Section 409A to the extent provided in the exceptions in Treasury
Regulation 1.409A-1(b)(4) and (b)(9) and other applicable provisions of Treasury Regulation
Section 1.409A-1 through A-6. Each individual installment payment that becomes payable under
this Agreement, and each payment of Base Salary after a Termination Date, shall be a “separate
payment” under Section 409A. The payment or reimbursement of any expense under this Agreement
in one of the Executive’s taxable years shall not affect the payment or reimbursement of any
expense

19

 

	 	 	in any other taxable year of the Executive. Any payment or reimbursement for expenses under
this Agreement shall in any event be made on or before the last day of the Executive’s
taxable year following the taxable year in which the expense was incurred, and any such
payment or reimbursement may not be liquidated or exchanged for any other benefit.
	 
	7.	 	Confidentiality.
	 
	(a)	 	The Executive agrees that, during the Term and at all times thereafter, he shall not reveal
or utilize Confidential Information (as defined in this Agreement) that he acquired during the
course of or as a result of his employment with the Company and that relates to (x) the CNA
Companies and any of their Affiliates or (y) the CNA Companies’ customers, employees, agents,
brokers and vendors. The Executive acknowledges that all such Confidential Information is
commercially valuable and is the property of the CNA Companies. Upon the termination of his
employment hereunder, the Executive shall return all such Confidential Information to the
Company, whether it exists in written, electronic, computerized or other form.
Notwithstanding anything elsewhere to the contrary (including, without limitation, in Exhibit
B), the Executive (a) may disclose Confidential Information (i) to the Company and its
Affiliates, or to any authorized (or apparently authorized) agent or representative of any of
them, (ii) in confidence to any attorney or accountant actually retained by Executive for the
purpose of securing professional advice (but not the Company’s privileged information), or
(iii) when required to do so by law or by a court, governmental agency, legislative body,
arbitrator or other Person with jurisdiction to order him to divulge, disclose or make
accessible such information, and (b) may disclose or use Confidential Information (i) with the
Company’s prior written consent, (ii) in connection with performing his duties hereunder or
(iii) in connection with any Proceeding under Section 15 or 24. In the event that the
Executive is required to disclose any Confidential Information pursuant to clause (a)(iii) or
(b)(iii)of the immediately preceding sentence, he shall (A) promptly give the Company advance
notice that such disclosure may be made and (B) not oppose and affirmatively cooperate with
the Company, at its reasonable request and sole expense, in seeking to protect the
confidentiality of the Confidential Information. (a) For purposes of this Agreement
“Confidential Information” shall mean information, knowledge or data (whether or not a trade
secret or protected by laws pertaining to intellectual property and including, without
limitation, information relating to data, finances, marketing, pricing, profit margins,
underwriting, claims, legal matters, loss control, marketing and business plans, renewals,
software, processing, vendors, administrators, customers or prospective customers, products,
brokers, agents and employees), other than information, knowledge or data that (x) has
previously been disclosed to the public, or is in the public domain,

20

 

	 	 	other than as a result of the Executive’s breach of this Section 7, or (y) is known or
generally available to the public or within any trade or industry of the Company or any of
its Affiliates.
	 
	(b)	 	The Executive agrees to execute, as of the Commencement Date, a Confidentiality, Computer
Responsibility and Professional Certification Agreement in the form attached hereto as Exhibit
B; provided, however, that the Executive’s obligation to maintain confidentiality and
return Company property will be governed by Section 7(a) and Section 12 of this Agreement,
respectively. The Company shall supply to the Executive, no later than twenty-one (21) days
prior to the Commencement Date, a copy of any additional document that he will be requested to
sign, acknowledge, or otherwise accept, in connection with commencing employment hereunder.
	 
	8.	 	Competition. The Executive hereby agrees that, during the Term and for 24 months thereafter,
he will not, directly or indirectly, perform services for, or otherwise have any involvement
with (other than in connection with performing services hereunder), in each case, whether as
an officer, director, partner, consultant, security holder, owner, employee, independent
contractor or otherwise, any Person that competes (whether directly or indirectly) with the
Company or its Affiliates in the Business in the United States, Europe, Canada, Argentina or
any other country in which any of the CNA Companies is conducting business as of the
Termination Date (any such Person, a “Competitor”); provided, however, that the
Executive may in any event (x) own up to a 5% passive ownership interest in any public or
private entity and (y) be employed by, or otherwise have material association with, any
business that competes materially with the Company or its Affiliates in the Business if his
employment or association is with a separately managed and operated division or Affiliate of
such business that does not compete with the Company or its Affiliates in the Business and he
has no business communication relating to the Business with employees of any division or
Affiliate of such business that does compete with the Company or its Affiliates in the
Business. For purposes of this Agreement, the term “Business” shall mean (a) any line of
commercial property and casualty insurance or (b) any other revenue producing activity in
which the Company or its Affiliates are involved as of the Termination Date; provided,
however, that such other revenue producing activity constitutes at least 2.5% of the Company’s
consolidated revenue in the year of, or the year immediately prior to, the Executive’s
termination of employment. Upon the written request of the Executive, the Board will
reasonably determine whether a business or other entity constitutes a “Competitor” for
purposes of this Section 9; provided that the Board may require the Executive to
provide such information as the Board determines to be necessary to make such determination;
and provided, further that the current and continuing effectiveness of such
determination

21

 

	 	 	may be conditioned upon the accuracy of such information, and upon such other factors as the
Board may determine.
	 
	9.	 	Solicitation. The Executive agrees that, during the Term and for 36 months thereafter,
he will not, directly or indirectly, solicit any individual (other than his own personal
assistant) who is then an employee of the Company or any of its Affiliates to terminate such
employee’s employment with the Company or its Affiliates or to accept employment elsewhere,
other than in connection with terminating, or altering, the employment of such employee in
connection with performing services hereunder.
	 
	10.	 	Non-interference. The Executive agrees that, during the Term and for 36 months
thereafter, he will not, directly or indirectly, other than in connection with performing
services hereunder and in the interest of the Company, solicit any Person that to his
knowledge had a business relationship with the Company or its Affiliates at any time during
the Term to terminate, or reduce, any such business relationship.
	 
	11.	 	Assistance with Claims. The Executive agrees that, during the Term and for a reasonable
period thereafter, and for no less than 36 months thereafter, he will make himself
available, on reasonable request, to assist the Company or any of its Affiliates in the
prosecution or defense of any Claim that may be made or threatened by or against the Company
or any of its Affiliates, and that relates to events, acts or omissions occurring during the
Term, by meeting with representatives of the Company (including attorneys) and providing
truthful and accurate information; provided, however, that he shall in no event be
required to (i) waive any constitutional rights or privileges, (ii) cooperate in connection
with a Claim brought by the Company against the Executive or a Claim brought by the
Executive against the Company, or (iii) disclose confidential information of any third party
which Executive is legally bound to maintain as confidential. The Executive agrees, unless
precluded by law or, in the case of requests from governmental and quasi-governmental
entities, reasonably advised to proceed otherwise by counsel, to promptly inform the Company
in advance if he is requested (i) to testify or otherwise become involved in connection with
any Claim against the interests of the Company or any of its Affiliates or (ii) to assist or
participate in any investigation (whether governmental or private) of the Company or any of
its Affiliates, whether or not a lawsuit has been filed against the Company or any of its
Affiliates relating thereto. The Company agrees to promptly reimburse the Executive for any
expenses he reasonably incurs in connection with his obligations under this Section 11,
including, without limitation, transportation (and, for this purpose, the Executive shall be
permitted to travel via Company aircraft if it is available, at no charge to the Executive),
lodging, meal expenses, and attorney’s fees (and other charges of counsel). The Company
agrees to

22

 

	 	 	make all reasonable efforts to minimize any inconvenience to the Executive that may be
created by his obligations under this Section 11. Nothing in this Agreement or elsewhere is
intended or shall be construed to prevent the Executive from cooperating fully with any
governmental investigation or review. For purposes of this Agreement, “Claim” shall mean
any claim, demand, request, investigation, dispute, controversy, threat, discovery request,
or request for testimony or information.
	 
	12.	 	Return of Materials. The Executive shall, at any time upon the request of a duly
authorized officer of the Company, and in any event promptly following the Termination Date,
return and surrender to the Company all property of the Company, including but not limited
to originals and all copies, regardless of medium, of property belonging to the Company
created or obtained by the Executive as a result of or in the course of or in connection
with his employment with the Company regardless of whether such items constitute proprietary
information; provided, however, that the Executive shall be under no obligation to
return written materials acquired from third parties that are generally available to the
public. Notwithstanding anything to the contrary in this Agreement or elsewhere (including,
without limitation, Exhibit B), the Executive shall be entitled to retain: (i) his home
computer, (ii) papers and other materials of a personal nature, including, but not limited
to, photographs, correspondence, personal diaries, calendars and Rolodexes, personal files
and phone books (including information on personal and professional contacts in whatever
form maintained), (iii) information relating to his compensation or to reimbursement of
expenses, (iv) information that he reasonably believes may be needed for tax purposes, and
(v) any other documents or information that relate to his personal entitlements or
obligations.
	 
	13.	 	Non-Disparagement. The Executive agrees that he shall not make any public statement at any
time after the Term that disparages the CNA Companies, or any of their officers or directors.
The Company shall instruct its directors and officers not to make any public statement at any
time after the Term that disparages the Executive. Notwithstanding the foregoing, nothing in
this Agreement or elsewhere shall prevent any Person from (i) responding publicly to
incorrect, disparaging or derogatory public statements to the extent reasonably necessary to
correct or refute such public statements or (ii) making any truthful statement to the extent
(y) reasonably necessary in connection with any litigation, arbitration or mediation or (z)
required by law or by any court, arbitrator, mediator or administrative or legislative body
(including any committee thereof) with apparent jurisdiction to order such Person to disclose
or make accessible such information.

23

 

	14.	 	Scope of Covenants.

	 	(a)	 	The Executive acknowledges that: (i) as a senior executive of the Company, he
will have access to confidential information concerning the entire range of businesses
in which the CNA Companies were and are engaged; (ii) that the CNA Companies’
businesses are conducted world-wide; and (iii) that the CNA Companies’ confidential
information, if disclosed or utilized without its authorization, would irreparably harm
the CNA Companies in: (1) obtaining renewals of existing customers; (2) selling new
business; (3) maintaining and establishing existing and new relationships with
employees, agents, brokers and vendors; and (4) other ways arising out of the conduct
of the businesses in which the CNA Companies are engaged.
	 
	 	(b)	 	To protect such information and such existing and prospective relationships,
and for other significant business reasons, the Executive agrees that it is reasonable
and necessary that: (i) the scope of this Agreement be world-wide; (ii) its breadth
include those segments of the entire insurance industry in which the CNA Companies
conduct business; and (iii) the duration of the restrictions upon the Executive be as
indicated herein.
	 
	 	(c)	 	The Executive acknowledges that the CNA Companies’ customer, employee and
business relationships are long-standing, indeed, near permanent, and therefore are of
great value to the CNA Companies. The Executive agrees that the provisions of Sections
7, 8, 9, 10, 12 and 13 of this Agreement, and the Company’s enforcement of them, are
reasonably necessary to protect the CNA Companies’ legitimate business and property
interests and relationships, especially those that he was responsible for developing or
maintaining.
	 
	 	(d)	 	The Company shall not condition any compensation or other benefits provided
under this Agreement on covenants that are more restrictive than those set forth in
this Agreement.
	 
	 	(e)	 	If any one or more of the provisions contained in Sections 7, 8, 9, 10, 11, 12
or 13 shall be held to be excessively broad as to duration, geographic scope, activity
or subject, such provisions shall be construed by limiting and reducing them so as to
be enforceable to the maximum extent allowed by applicable law.

24

 

	15.	 	Equitable Relief. Each Party agrees that any actual or threatened breach of the covenants
set forth in Sections 7, 8, 9, 10, 12 or 13 above could cause the other Party irreparable
harm. Therefore, in the event of any actual or threatened breach by either Party (the
“Breaching Party”) of the provisions of Section 7, 8, 9, 10, 12 or 13 above, the other Party
shall be entitled to seek, through arbitration in accordance with Section 24 or from any court
with jurisdiction over the matter and the defendant(s), temporary, preliminary and/or
permanent equitable/injunctive relief restraining the Breaching Party from violating such
provisions and to seek, in addition, but solely through arbitration in accordance with Section
24, money damages, together with any and all other remedies available under applicable law.
	 
	16.	 	Change in Control. Upon the occurrence of any Change in Control, any unvested SARs and any
earned but unvested RSUs held by the Executive shall become fully vested (i.e.,
non-forfeitable), and any SARs that are or become vested shall become exercisable. For
purposes of this Agreement, “Change in Control” shall mean the occurrence of any of the
following events: (i) any “person” or “group”, other than Loews Corporation and its
Affiliates, is or becomes the “beneficial owner”, as such terms are used as of the Signing
Date in Rule 13d-3 promulgated under the 1934 Act, of a percentage of the Voting Stock of the
Company (measured either by number of securities or by number of votes entitled to be cast)
that is greater than both (x) the percentage of the Voting Stock of the Company (thus
measured) then held by Loews Corporation and its Affiliates and (y) 20%; (ii) the Company
combines with another entity and is not the surviving entity; or (iii) all or substantially
all of the assets or business of the Company is disposed of pursuant to a sale, merger,
consolidation, liquidation or other transaction or series of transactions, unless the holders
of Voting Stock of the Company immediately prior to such combination, transaction or series of
transactions (collectively, a “Triggering Event”) own, directly or indirectly, by reason of
their ownership of Voting Stock of the Company immediately prior to such Triggering Event, a
majority of the Voting Stock (measured both by number of securities and by voting power) of
the entity, if any, that succeeds to all or substantially all of the assets and business of
the Company. For purposes of this Agreement, “Voting Stock” shall mean issued and outstanding
capital stock or other securities of any class or classes having general voting power, under
ordinary circumstances in the absence of contingencies, to elect, in the case of a
corporation, the directors of such corporation and, in the case of other entities, the
corresponding governing person or body; and “1934 Act” shall mean the Securities Exchange Act
of 1934, as amended.

25

 

	17.	 	Representations.

	 	(a)	 	The Executive represents and warrants to the Company that he (i) has the legal
right to enter into this Agreement and to perform all of the obligations to be
performed by him hereunder in accordance with its terms, (ii) is not a party to any
agreement or understanding, written or oral, that would prevent him from entering into
this Agreement or performing his obligations under it, and (iii) has not materially
breached any of his fiduciary duties to his current employer or its Affiliates. The
Executive represents and warrants to the Company that he is not a party to any
non-compete or non-solicitation obligations with any Person, including his current
employer, or its Affiliates, other than the “Restrictive Covenants” and obligations
that have now expired. For purposes of this Agreement, “Restrictive Covenants” means
the Executive’s non-compete, non-solicit and other obligations to his current employer
and its Affiliates, including any restrictions on his activities violation of which
could lead to loss of benefits, as provided in (x) the Restricted Stock Unit Agreements
between the Executive and his current employer, dated March 3, 2005 (as amended), March
2, 2006, March 1, 2007, and March 12, 2008, and (y) the Performance Share Award
Agreements between the Executive and his current employer, dated March 3, 2005 (as
amended), March 2, 2006 (as amended), March 1, 2007, and March 12, 2008.
	 
	 	(b)	 	The Company represents and warrants that (i) it is fully authorized by action
of its Board (and of any other Person or body whose action is required) to enter into
this Agreement and to perform its obligations under it, (ii) the execution, delivery
and performance of this Agreement by it does not violate any applicable law,
regulation, order, judgment or decree, or any agreement, arrangement, plan or corporate
governance document to which it is a party or by which it is bound and (iii) upon the
execution and delivery of this Agreement by the Parties, this Agreement shall be its
valid and binding obligation, enforceable against it in accordance with its terms,
except to the extent that enforceability may be limited by applicable bankruptcy,
insolvency or similar laws affecting the enforcement of creditors’ rights generally.
	 
	 	(c)	 	The Parties agree that there will be no contact prior to the Commencement Date
between the Parties that violates the Restrictive Covenants. Notwithstanding anything
in this Agreement to the contrary, the Executive agrees that he will not at any time
violate the Restrictive Covenants or his fiduciary or other obligations

26

 

	 	 	 	to his current employer and its Affiliates and that he will not become a party to
any agreement or understanding, written or oral, that would prevent him from
entering into this Agreement or performing his obligations under it. The Executive
agrees that if the Executive’s non-compete and non-solicit obligations under the
Restrictive Covenants should expire earlier than the date set forth in the
Restrictive Covenants (as in effect on the Signing Date), he will promptly inform
the Company and he will cooperate with the Company to determine an earlier
Commencement Date that is mutually agreeable to the Parties.

	18.	 	Indemnification, Advancement of Expenses, D&O Insurance.

	 	(a)	 	If the Executive is made a party, is threatened to be made a party, or
reasonably anticipates being made a party, to any Proceeding by reason of the fact that
he is or was a director, officer, member, employee, agent, manager, trustee, consultant
or representative of the Company or any of its Affiliates, or is or was serving at the
request of the Company or any of its Affiliates, or in connection with his service
hereunder, as a director, officer, member, employee, agent, manager, trustee,
consultant or representative of another Person, or if any Claim is made, is threatened
to be made, or is reasonably anticipated to be made, that arises out of or relates to
the Executive’s service in any of the foregoing capacities, then the Executive shall
promptly be indemnified and held harmless to the fullest extent permitted or authorized
by the Certificate of Incorporation or Bylaws of the Company, or if greater, by
applicable law, against any and all reasonable and appropriately documented costs,
expenses, liabilities and losses (including, without limitation, attorneys’ and other
professional fees and charges that are reasonably incurred, judgments, interest,
expenses of investigation that are reasonably incurred, penalties, fines, ERISA excise
taxes or penalties and reasonable amounts paid or to be paid in settlement) incurred or
suffered by the Executive in connection therewith, and such indemnification shall
continue as to the Executive even if he has ceased to be a director, officer, member,
employee, agent, manager, trustee, consultant or representative of the Company or other
Person and shall inure to the benefit of his heirs, executors and administrators. The
Executive shall be entitled to prompt advancement of any and all appropriately
documented costs and expenses (including, without limitation, attorneys’ and other
professional fees and charges) reasonably incurred by him in connection with any such
Proceeding or Claim, any such advancement to be made within 15 days after the Executive
gives written notice, supported by reasonable documentation, requesting such
advancement. Such notice shall include an undertaking by the Executive to repay the
amounts advanced to the extent that he

27

 

	 	 	 	is ultimately determined not to be entitled to indemnification against such costs
and expenses. Nothing in this Agreement or elsewhere shall operate to limit or
extinguish any right to indemnification, advancement of expenses, or contribution
that the Executive would otherwise have (including, without limitation, by agreement
or under applicable law). For purposes of this Agreement, “Proceeding” shall mean
any actual, threatened or reasonably anticipated action, suit or proceeding, whether
civil, criminal, administrative, investigative, appellate, formal, informal or
other.
	 
	 	(b)	 	Neither (i) the failure of the Company (including its Board, independent legal
counsel or stockholders) to have made a determination prior to the commencement of any
Proceeding concerning payment of amounts claimed by the Executive under Section 18(a)
that indemnification of the Executive is proper because he has met the applicable
standard of conduct, nor (ii) a determination by the Company (including its Board,
independent legal counsel or stockholders) that the Executive has not met such
applicable standard of conduct, shall create a presumption that the Executive has not
met the applicable standard of conduct.
	 
	 	(c)	 	A directors’ and officers’ liability insurance policy (or policies) shall be
kept in place, during the Term and for six years thereafter, to the extent that such
coverage is then provided to any other current or former director or executive officer
of the Company, providing coverage to the Executive that is no less favorable to him in
any respect (including, without limitation, with respect to scope, exclusions, amounts,
and deductibles) than the coverage then being provided to any other present or former
senior executive or director of the Company.

	19.	 	Current Employer Disputes. The Executive shall be entitled to prompt advancement of, and
indemnification against, any and all appropriately documented costs and expenses (including,
without limitation, attorneys’ and other professional fees and charges) reasonably incurred by
him in connection with any Proceeding or Claim (a “Covered Dispute”) that alleges or otherwise
involves, as a material issue in such Covered Dispute, any Claim that the Executive breached
any of the Restrictive Covenants or breached any of his fiduciary obligations to his current
employer or its Affiliates, in each case resulting from his employment or services hereunder,
or his agreement to become employed hereunder, or activities, if any, taken prior to the
Commencement Date at the express request of the Company, any such advancement to be made
within 15 days after the Executive gives written notice, supported by reasonable
documentation, requesting such advancement. To the extent that the Executive’s current
employer (or its Affiliates, if

28

 

	 	 	applicable) substantially and finally prevails with respect to any such Covered Dispute, the
Executive shall promptly repay any amounts advanced under this Section 19 with respect to
such Covered Dispute. For avoidance of doubt, the Company shall not be required to
indemnify the Executive against any final judgment obtained by his current employer or any
of its Affiliates with respect to any Covered Dispute in respect of which it has advanced
expenses under this Section 19. The Executive shall have the right to counsel of his choice
in connection with any Covered Dispute, subject to the Company’s consent (which shall not be
unreasonably withheld or delayed).  The Company shall have the right to resolve any Covered
Dispute with respect to which it has advanced legal fees or expenses under this Section 19,
provided, however, that the Executive’s rights and interests are not adversely
affected by any such resolution.
	 
	20.	 	Severability. Each of the terms and provisions of this Agreement shall be deemed
severable in whole and in part. To the extent that any provision or portion of this
Agreement shall be determined to be invalid or unenforceable for any reason, in whole or in
part, the remaining provisions of this Agreement shall remain in full force and effect so as
to achieve the intentions of the Parties, as set forth in this Agreement, to the maximum
extent possible.
	 
	21.	 	Assignment.

	 	(a)	 	This Agreement shall be binding upon, and inure to the benefit of, the Parties
and their respective successors, heirs (in the case of the Executive) and assigns.
	 
	 	(b)	 	No rights or obligations of the Company under this Agreement may be assigned or
transferred by the Company except that such rights and obligations may be
assigned or transferred pursuant to a merger, consolidation or other combination in
which the Company is not the continuing entity, or a sale or liquidation of all or
substantially all of the business and assets of the Company, provided that the
assignee or transferee is the successor to all or substantially all of the business and
assets of the Company and such assignee or transferee expressly assumes the
liabilities, obligations and duties of the Company as set forth in this Agreement.
	 
	 	(c)	 	No rights or obligations of the Executive under this Agreement may be assigned
or transferred by the Executive other than his rights to compensation and benefits,
which may be transferred only by will or by operation of law. Notwithstanding the
foregoing, the Executive shall be entitled, to the extent permitted under

29

 

	 	 	 	applicable law and applicable Company Arrangements, to select and change a
beneficiary or beneficiaries to receive any compensation or benefit hereunder
following the Executive’s death by giving written notice thereof to the Company. In
the event of the Executive’s death or a judicial determination of his incompetence,
references in this Agreement to the Executive shall be deemed, where appropriate, to
refer to his beneficiary, estate or other legal representative. In the event that
Executive dies before all payments he may be entitled to have been paid, all
remaining payments shall be made to the beneficiary specifically designated by the
Executive in writing prior to his death, or, if no such beneficiary was designated
(or the Company is unable in good faith to determine the beneficiary designated), to
his personal representative or estate.

	22.	 	Miscellaneous.

	 	(a)	 	This Agreement shall be governed, interpreted, performed and enforced in
accordance with its express terms, and otherwise in accordance with the laws of the
State of Delaware (without regard to choice of law or conflict of laws principles), to
the extent not displaced by federal law.
	 
	 	(b)	 	Except as otherwise expressly set forth herein, this Agreement contains the
entire agreement of the Parties with regard to the subject matter hereof, and
supersedes all prior agreements and understandings, written or oral, with respect to
such subject matter.
	 
	 	(c)	 	No provision in this Agreement may be amended unless such amendment is set
forth in a writing that expressly refers to the provision of this Agreement that is
being amended and that is signed by the Executive and by an authorized officer of the
Company. No waiver by any Person of any breach of any condition or provision contained
in this Agreement shall be deemed a waiver of any similar or dissimilar condition or
provision at the same or any prior or subsequent time. To be effective, any waiver
must be set forth in a writing signed by the waiving Person and must specifically refer
to the condition(s) or provision(s) of this Agreement being waived. In the event of
any conflict between any provision of this Agreement and any provision of any Company
Arrangement, the provisions of this Agreement shall control unless the Executive
otherwise agrees in a writing that expressly refers to the provision of this Agreement
whose control he is waiving.

30

 

	 	(d)	 	Except as otherwise expressly set forth in this Agreement, the respective
rights and obligations of the Parties (including, without limitation, those set forth
in Sections 6 through 19 above and Sections 23 through 25 below) shall survive any
termination of the Executive’s employment hereunder.
	 
	 	(e)	 	All numbers and headings contained in this Agreement are for reference only and
are not intended to qualify, limit or otherwise affect the meaning or interpretation of
any provision contained in this Agreement.

	23.	 	Notices. Any notice, consent, demand, request, or other communication given to a Person in
connection with this Agreement shall be in writing and shall be deemed to have been given to
such Person (x) when delivered personally to such Person or (y), provided that a written
acknowledgment of receipt is obtained, five days after being sent by prepaid certified or
registered mail, or two days after being sent by a nationally recognized overnight courier, to
the address (if any) specified below for such Person (or to such other address as such Person
shall have specified by ten days’ advance notice given in accordance with this Section 23) or
(z) on the first business day after it is sent by facsimile to the facsimile number (if any)
set forth below (or to such other facsimile number as shall have specified by ten days’
advance notice given in accordance with this Section 23), with a confirmatory copy sent by
certified or registered mail or by overnight courier in accordance with this Section 23.

If to the Company:

CNA Financial Corporation

CNA Center

Chicago, IL 60685

Attn: Corporate Secretary

Fax: 312-817-0511

If to the Executive:

The address of his principal residence as it appears in the Company’s records, with
a copy to him (during the Term) at his office in Chicago, and a copy to:

Morrison Cohen LLP.

909 Third Avenue

New York, NY 10022

Attn: Robert M. Sedgwick

Fax: 212-735-8708

31

 

If to beneficiary of the Executive:

The address most recently specified by the Executive or beneficiary.

	24.	 	Arbitration of All Disputes. Any Claim between the Executive and the Company or any of
its Affiliates, including any Claim arising out of or relating to this Agreement, any other
agreement or arrangement between the Executive and the Company or any of its Affiliates, the
Executive’s employment with the Company, or any termination thereof (a “Covered
Claim”) shall (except to the extent otherwise provided in Section 15 with respect to
certain requests for injunctive relief) be resolved by binding confidential arbitration, to
be held in Chicago, Illinois, in accordance with the Commercial Arbitration Rules (and not
the National Rules for Resolution of Employment Disputes) of the American Arbitration
Association and this Section 24. Judgment upon the award rendered by the arbitrator(s) may
be entered in any court having jurisdiction thereof. The Company shall advance to (or for
the benefit of) the Executive (or his beneficiaries, as applicable), promptly upon written
request, any appropriately documented costs or expenses (including, without limitation,
attorneys’ fees and other charges of counsel) reasonably incurred by the Executive or his
beneficiaries in connection with any Covered Claim, subject to prompt repayment to the
extent that the Company (and its Affiliates, as applicable) are determined to have
substantially prevailed with respect to such Covered Claim.
	 
	25.	 	Section 280G Gross-Up. In the event that any payment or benefit made or provided to or
for the benefit of the Executive under this Agreement, or under any plan, agreement, program
or arrangement of the Company, of any Person effecting a change in control of the Company,
or any Affiliates of any of the foregoing (a “Payment”) is determined to be subject to any
excise tax (“Excise Tax”) imposed by Section 4999 of the Code, or any comparable state or
local tax provision, the Company shall pay to the Executive at or prior to the time any
Excise Tax is payable with respect to such Payment (through withholding or otherwise), an
additional amount which, after the imposition of all income, employment, excise and other
taxes payable by the Executive thereon, is equal to the sum of (i) the Excise Tax on such
Payment plus (ii) any penalty and interest assessments associated with such Excise Tax. The
determination of whether any Payment is subject to the Excise Tax and, if so, the amount to
be paid by the Company to the Executive and the time of payment pursuant to this Section 25
shall be made by an independent, nationally recognized United States public accounting firm
(the “Auditor”) assuming in all cases taxation at the highest applicable marginal rates.
The Auditor shall be selected by the Company (subject to the Executive’s approval, which
shall not be unreasonably

32

 

	 	 	withheld or delayed), and shall be paid for by the Company. The Parties shall cooperate
with each other in connection with any Proceeding or Claim relating to the existence or
amount of any liability for any Excise Tax. The Company shall have the right to control the
conduct of and to resolve and compromise any Claim or Proceeding subject to the remainder of
this Section 25, and provided the Executive’s rights and interests are not adversely
affected by any such resolution or compromise. All appropriately documented expenses
relating to any such Proceeding or Claim (including any attorneys’ fees and other expenses
associated therewith) reasonably incurred by the Executive shall be paid by the Company
promptly upon demand by the Executive, and any such payment shall be grossed up for all
taxes (assuming taxation at the highest applicable marginal rates) in the event that the
Executive is subject to any income tax, employment tax or Excise Tax on it. All payments
under this Section 25 shall be made within the time periods required by Treasury Regulation
§ 1.409A-3(i)(1)(v).

[Remainder of the page intentionally left blank.]

33

 

	26.	 	Counterparts. This Agreement may be executed in one or more counterparts, each of which
shall be deemed to be an original copy of this Agreement and all of which, when taken
together, shall be deemed to constitute one and the same agreement. Signatures delivered by
facsimile shall be deemed effective for all purposes.
	 
	 	 	IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the Signing Date.

	 	 	 	 	 
	CNA FINANCIAL CORPORATION	 	 
	 
	 	 	 	 
	By:

	 	/s/ Jonathan D. Kantor
 

	 	 
	Name: Jonathan D. Kantor	 	 
	Title: Executive Vice-President	 	 
	 
	 	 	 	 
	THOMAS F. MOTAMED	 	 
	 
	 	 	 	 
	/s/ Thomas F. Motamed

	 	 
	 	 	 

34

 

EXHIBIT A

FORM OF RELEASE

          THIS RELEASE OF CLAIMS (this “Release”) is entered into as of                      [the date the
Executive signs this Release following a termination without Cause or a resignation for Good
Reason] (the “Release Date”), by and between Thomas F. Motamed (the “Executive”) and CNA Financial
Corporation (the “Company”). Capitalized terms used but not defined herein shall have the meanings
ascribed to such terms in the Employment Agreement by and between the Company and the Executive,
dated as of May 22, 2008 (the “Employment Agreement”).

          1. Release.

               (a) The Executive, on behalf of himself and his beneficiaries, estate and legal
representatives (collectively, with the Executive, the “Executive Releasors”) hereby releases,
acquits and forever discharges the Company, its Affiliates, and each of their respective
successors, assigns, officers, directors, and employees (collectively, the “Company Released
Parties”) from any and all claims, causes of actions, demands, suits, costs, expenses and damages
of whatsoever nature and kind, whether known or unknown, whether now existing or hereafter arising,
at law or in equity, that any Executive Releasor may have, or may have had, or may hereafter have,
and that are based in whole or in part on facts, whether or not now known, existing prior to the
Release Date, and that arise out of or relate to the Executive’s employment with or services for
the Company or its Affiliates, or the termination of such employment or services, other than claims
arising under or preserved by Section 6 of the Employment Agreement.

               (b) The claims released by the Executive include, to the extent set forth in Section 1(a), any
and all claims under federal, state or local laws pertaining to employment, including the Age
Discrimination in Employment Act of 1967, as amended, Title VII of the Civil Rights Act of 1964, as
amended, 42 U.S.C. Section 2000e et seq., the Fair Labor Standards Act as amended, 29 U.S.C.
Section 201 et seq., the Americans with Disabilities Act, as amended, 42 U.S.C. Section 12101 et
seq., the Reconstruction Era Civil Rights Act, as amended, 42 U.S.C. Section 1981 et seq., the
Rehabilitation Act of 1973, as amended, 29 U.S.C. Section 701 et seq., the Family and Medical Leave
Act of 1992, 29 U.S.C. Section 2601 et seq., and any and all state or local laws regarding
employment discrimination and/or U.S. federal, state or local laws of any type or description
regarding employment, including but not limited to any claims in any way arising from or derivative
of the Executive’s employment with the Company or any of

35

 

its Affiliates or the termination of such employment, as well as any claims under state
contract or tort law or otherwise.

               2. Representation by the Executive. The Executive represents that he has not been convicted
of, or pleaded guilty to or nolo contendere to, any felony and has not engaged in conduct that
constitutes Cause under the Employment Agreement.

               3. Incorporation of Specific Provisions. The following Sections of the Employment Agreement
shall be deemed incorporated by reference in this Release and shall be treated as if set forth in
full herein, except that references in them to this “Agreement” shall be deemed to be references to
this “Release”: Sections 17(b), 20, 21(a), 21(c) (last sentence only), 22(a), 22(b), 22(c), 22(e),
23, 24, and 26.

               4. Review and Revocation Period. The Executive hereby represents that he has read this
Release carefully and fully understands the terms hereof, and that he has been advised to consult
with an attorney and has had the opportunity to consult with an attorney prior to signing this
Release. The Executive acknowledges that he is executing this Release voluntarily and knowingly,
without duress or coercion, and that he has not relied on any representations, promises or
agreements of any kind, other than those set forth in this Release. The Executive further
represents that he has had 21 days to review this Release. If the Executive has executed this
Release in fewer than 21 days after its delivery, the Executive hereby acknowledges that his
decision to execute this Release prior to the expiration of such 21-day period was entirely
voluntary. The Executive may revoke his acceptance of this Release within seven days after he has
signed it and delivered it to the Company (the “Revocation Period”) by sending written notice to
the Company that the Executive wishes to revoke his acceptance of it and not be bound by it. If
the Executive timely revokes this Release, the Company shall have no obligation to provide to the
Executive the benefits described in Sections 6.3(a)(i) and 6.3(a)(ii) of the Employment Agreement.
This Release shall become effective on the seventh (7th) day after the Executive signs
it unless revoked in accordance with the procedure set forth in the prior sentence. This Release
shall be null and void if not countersigned by the Company, and delivered to the Executive, within
seven (7) days after the expiration of the Revocation Period.

               IN WITNESS WHEREOF, the Parties have executed this Release as of the date and year first above
written.

	 	 	 	 	 
	 

	 	THOMAS F. MOTAMED	 	 
	 
	 	 	 	 
	 

	 	 

Date:
	 	 

36

 

EXHIBIT B

CONFIDENTIALITY, COMPUTER RESPONSIBILITY AND

PROFESSIONAL CERTIFICATION AGREEMENT

To protect the confidentiality of company information and the integrity of CNA’s business
relationships, employees are required to comply with the following company policies concerning:

	•	 	Confidentiality
	 
	•	 	Computer Responsibility
	 
	•	 	Professional Conduct

CNA employees (collectively referred to as “CNA personnel” or “CNA”) are required to read and
comply with this Agreement. CNA reserves the right to add or change the requirements contained in
this Agreement.

I. CONFIDENTIALITY AGREEMENT

Background

Confidentiality is an extremely serious concern in today’s world because of the increasingly high
value firms place on information and its critical importance to their competitive survival.

Agreement

I understand that during my employment with Continental Casualty Company I will have access to
information from Continental Casualty Company, Continental Corporation, CNA Financial Corporation
and their subsidiaries, affiliates, agents, policyholders, claimants, suppliers, vendors,
licensers, any or all of which are referred to in the Agreement as “CNA.” I also understand that
this information, whether technical or non-technical, is commercially valuable. It is referred to
in the Agreement as “Confidential Information.”

Examples of Confidential Information include, but are not limited to all of the types of
Confidential Information which I may develop or to which I may have access:

	•	 	Information of a business nature, such as marketing, underwriting, employee and customer
data, sales and lists of customers, including future developments and planning concerning
them.
	 
	•	 	Computer/software programs and associated documentation and material which are proprietary
to CNA or to which CNA is under an obligation to prevent disclosure.
	 
	•	 	Information from CNA customers, vendors or suppliers which is confidential, proprietary or
copyrighted.

37

 

I hereby agree that:

	1.	 	The Confidential Information shall remain the sole and exclusive property of CNA and I shall
regard it as confidential and secret information.
	 
	2.	 	The Confidential Information is property to be considered to be the trade secrets of CNA
because it involves processes and compilations of information which are secret, confidential
and are not generally known to the public and which are the product of expenditures of time,
effort, money and/or creative skills of CNA.
	 
	3.	 	The Confidential Information is furnished to me during my employment on a confidential and
secret basis for the sole and exclusive use in pursuing my employment duties at CNA.
	 
	4.	 	I will not, during or after my employment with CNA, publish, disclose or otherwise divulge
the Confidential Information to any person not specifically authorized by CNA to receive such
information.
	 
	5.	 	I will not copy any Confidential Information for any purpose except with the express consent
of a CNA official or the express written authorization of the third party owner.
	 
	6.	 	Upon termination of my employment at CNA, or at any other time at CNA’s request, I agree to
return promptly to CNA all Confidential Information, including, but not limited to all
manuals, letters, notes, notebooks, reports, formulae, computer programs, and associated
documentation and material, memoranda, customer lists and all other materials and all copies
of them relating in any way to CNA’s business, which in any way were obtained by me during my
employment with CNA which are in my possession or under my control. I further agree that I
will not make or retain copies of any of the above mentioned information and will so represent
to CNA upon termination of my employment.
	 
	7.	 	I acknowledge that CNA would suffer irreparable harm for which both preliminary and final
injunctive relief would be an appropriate remedy in addition to such other relief to which CNA
may also be entitled.
	 
	8.	 	I acknowledge and agree that CNA employees in violation of this Agreement shall be liable for
the costs of CNA’s efforts to enforce it, including reasonable attorney’s fees.

The Confidentiality Agreement will continue to be in effect after termination of my employment at
CNA. If any provision of this Agreement is declared invalid or unenforceable with respect to a
particular occurrence or circumstance or otherwise, that will not affect the validity and
enforceability or applicability of any other provision of the Agreement.

38

 

II. COMPUTER USER STATEMENT OF RESPONSIBILITY

Background

The information you will have access to in your employment or association with CNA is often
protected by contract or Federal Law. CNA’s obligations are equally applicable to its employees.
There are often significant penalties for disclosing protected information to parties not
authorized in formal agreements to receive it. CNA takes its legal and contractual obligations to
assure the confidentiality of all such protected information with the utmost seriousness. As an
employee of CNA, you need to treat information with the same care and confidentiality that CNA, as
a corporation, is bound by its formal contracts to employ.

Policy

CNA’s computers and communications resources, and all related computer programs and their products,
may be used only for the purposes authorized and specified by CNA. Appropriate steps should be
taken to see that these resources are protected from accidents, tampering and unauthorized use or
modification. Questions regarding the appropriateness of planned usage of communications resources
should be directed to CNA management or Information Security Services (e-mail address, IT Security
Policy Support).

Computer Password Confidentiality

Computer passwords are confidential. If accidentally revealed, passwords should be changed
immediately. CNA personnel are responsible for any actions taken by persons using their passwords.

CNA personnel must comply with all password standards including those covering structure and change
frequency. Any possible or actual violation of data security or Systems Security Policy and
Standards that you witness or become aware of must be reported immediately to management or
Information Security Services (e-mail address, IT Security Policy Support).

Information stored on computer or removable media must be protected to prevent unauthorized access
to or disclosure of that information. The appropriate level of information protection will vary by
business organization. CNA personnel who have questions or who have not received specific
instructions concerning these requirements should contact their manager or Information Security
Services (e-mail address, IT Security Policy Support).

The Copyright Act

The Copyright Act is a Federal Law. It gives copyright owners of original works the exclusive right
to and control of the copying, distribution and display of their copyrighted works as well as to
the preparation of any derivative works. It is illegal to violate these rights.

39

 

It is CNA policy to comply fully with the Copyright Act. CNA employees who violate the copyright or
third party license restrictions in the course of their employment shall be subject to termination
or other disciplinary action.

Any questions related to copyright or CNA’s policy regarding copyright should be directed to the
Corporate Law Department.

Software

CNA software purchased or developed for use in connection with computers is proprietary and may not
be copied without the owner’s permission. Each piece of software that CNA has purchased is covered
by a written agreement with specific terms and conditions that address the confidentiality of the
software. All terms and conditions, including copyright and liability notices and back up
procedures that may apply to a software package must be followed. Any questions about the terms of
the contract governing software you use should be directed to your manager or Systems Security.

CNA licensed software and services are not owned by CNA and may not be reproduced unless authorized
by the software developer or vendor. CNA personnel or their agents discovered making, acquiring, or
using unauthorized copies of computer software or documentation will be subject to disciplinary
action or termination, as appropriate.

Introducing unauthorized software or utilities on CNA systems, adding software that is personally
purchased or developed for non-CNA business to CNA storage devices, or executing this software on
CNA computers is a violation of this policy.

Use of Information and Materials Obtained from On-line Services, Subscription Services, Electronic
Bulletin Boards and the Internet

Copyrighted programs, documentation, images, text or music are protected by copyright law. Federal
law protects processes and formulas embedded in programs. Downloading of copyrighted files,
including e-mail, file transfer protocol and all network downloads is illegal. To prevent viruses,
unauthorized downloading is prohibited. Authorized downloading requires controlled virus scans of
the files and receiving volume, drive and directory members.

Use of information or materials obtained from an on-line service, subscription service or
electronic bulletin board must comply with any requirements specified in the applicable license or
copyright restrictions. These requirements often include limiting the number of copies made,
deleting electronic copies from the user’s hard drive after a set period of time, prohibiting use
of all or any part of the information or materials in another document and paying royalties.

Before including written materials obtained from any on-line service, subscription service or
electronic bulletin board in a CNA publication, memorandum, software system or distributing

40

 

the materials in any way to other CNA employees or third parties, care should be taken to make
certain that CNA has appropriate authorization for such use. Contact your manager or Vendor
Contract Administration if you need assistance interpreting a license agreement.

Authorization should not be assumed from the absence of any prohibition. Particular care should be
taken for materials intended for broad publication or distribution.

Sharing of CNA Information and Materials

This section applies to all reports, documents, computer software, data and all other materials
owned by or licensed to CNA (the “Proprietary Information”), and is in addition to the provisions
of the Confidentiality agreement set forth on pages 1 and 2. Any works created by CNA employees in
the course of their employment are owned by CNA.

In general, Proprietary Information should not be distributed to third parties. Because the
Internet is neither private nor secure, every user is responsible for protecting the integrity of
company information and resources. Proprietary, private or confidential corporate information, data
or programs may not be exported or copied through the Internet. In general, CNA or third-party
proprietary information should not be distributed to an electronic bulletin board unless such
distribution furthers a clear business objective.

If Proprietary Information is transmitted, the user must determine whether the information is owned
by CNA or licensed from a third party. If it is owned by CNA, then a proprietary rights notice
should be included. The following are acceptable proprietary rights notices:

-”Copyright 199___CNA Financial Corporation and its subsidiaries and affiliates”

-”All rights reserved to CNA Financial Corporation and its subsidiaries and affiliates”

If the Proprietary Information is licensed by CNA from third parties, care should be taken to
confirm that the proposed use and disclosure of that information is permitted under the applicable
license agreement. Contact your manager or Vendor Contract Administration if you need assistance
interpreting a license agreement.

As representatives of CNA, all personnel have a responsibility to conduct themselves in a
businesslike manner, honoring all network rules, including, but not limited to:

-Avoiding defamatory or obscene language.

-Respecting the privacy rights of others.

-Refraining from mischievous or criminal conduct while on the Internet.

41

 

Failure to comply with the Agreements stated in this policy represents a violation of CNA
Information Systems Security Policy and Standards and may be grounds for disciplinary action or
termination.

III. COMMITMENT TO PROFESSIONAL CONDUCT

Background

One of the obligations of all CNA employees is to be committed to high standards of ethical and
professional conduct. CNA’s Our Commitment to Professional Conduct handbook (AG-129198) contains
important information about CNA policies, values and expectations on the way we do business and
alerts you to potential legal and ethical issues that you need to be aware of.

42

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00158-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00158-of-00352.parquet"}]]